{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Chinese medicine", "anti-osteoporosis", "bone health", "natural product", "osteoprotection"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26927052", "DateCompleted": {"Year": "2016", "Month": "11", "Day": "11"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "02", "Day": "27"}], "ELocationID": ["239", "10.3390/molecules21030239"], "Language": ["eng"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "21", "Issue": "3", "PubDate": {"Year": "2016", "Month": "Feb", "Day": "27"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Natural Products from Chinese Medicines with Potential Benefits to Bone Health.", "Pagination": {"StartPage": "239", "MedlinePgn": "239"}, "Abstract": {"AbstractText": ["Osteoporosis is a progressive, systemic bone disorder characterized by loss of bone mass and microstructure, leading to reduced bone strength and increased risk of fracture. It is often associated with reduced quality of life and other medical complications. The disease is common in the aging population, particularly among postmenopausal women and patients who receive long-term steroidal therapy. Given the rapid growth of the aging population, increasing life expectancy, the prevalence of bone loss, and financial burden to the healthcare system and individuals, demand for new therapeutic agents and nutritional supplements for the management and promotion of bone health is pressing. With the advent of global interest in complementary and alternative medicine and natural products, Chinese medicine serves as a viable source to offer benefits for the improvement and maintenance of bone health. This review summarizes the scientific information obtained from recent literatures on the chemical ingredients of Chinese medicinal plants that have been reported to possess osteoprotective and related properties in cell-based and/or animal models. Some of these natural products (or their derivatives) may become promising leads for development into dietary supplements or therapeutic drugs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The University of Illinois at Chicago, Chicago, IL 60612, USA. chect@uic.edu."}], "LastName": "Che", "ForeName": "Chun-Tao", "Initials": "CT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China. man-sau.wong@polyu.edu.hk."}], "LastName": "Wong", "ForeName": "Man Sau", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, China. wklam@must.edu.mo."}], "LastName": "Lam", "ForeName": "Christopher Wai Kei", "Initials": "CW"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Bone Density Conservation Agents"}], "MeshHeadingList": [{"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Aging"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Biological Products"}, {"QualifierName": ["drug effects"], "DescriptorName": "Bone Density"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Bone Density Conservation Agents"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Bone and Bones"}, {"QualifierName": ["analysis"], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["metabolism", "pathology", "prevention & control"], "DescriptorName": "Osteoporosis"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "International Osteoporosis Foundation: Facts and Statistics about Osteoporosis and Its Impact.  [(accessed on 14 December 2015)].  Available online:  http://www.iofbonehealth.org/facts-and-statistics.html."}, {"Citation": "Korpi-Steiner N., Milhorn D., Hammett-Stabler C. Osteoporosis in men. Clin. Biochem. 2014;47:950\u2013959. doi: 10.1016/j.clinbiochem.2014.03.026.", "ArticleIdList": ["10.1016/j.clinbiochem.2014.03.026", "24726494"]}, {"Citation": "National Osteoporosis Foundation Prevalence Report.  [(accessed on 4 December 2015)].  Available online:  http://www.nof.org/advocacy/resources/prevalencereport."}, {"Citation": "Management of osteoporosis in postmenopausal women: 2010 position statement of the North American menopause society. Menopause. 2010;17:25\u201354.", "ArticleIdList": ["20061894"]}, {"Citation": "Tella S.H., Gallagher J.C. Prevention and treatment of postmenopausal osteoporosis. J. Steroid Biochem. Mol. Biol. 2014;142:155\u2013170. doi: 10.1016/j.jsbmb.2013.09.008.", "ArticleIdList": ["10.1016/j.jsbmb.2013.09.008", "PMC4187361", "24176761"]}, {"Citation": "Lin X., Xiong D., Peng Y.Q., Sheng Z.F., Wu X.Y., Wu X.P., Wu F., Yuan L.Q., Liao E.Y. Epidemiology and management of osteoporosis in the People\u2019s Republic of China: Current perspectives. Clin. Interv. Aging. 2015;10:1017\u20131033.", "ArticleIdList": ["PMC4485798", "26150706"]}, {"Citation": "Sandhu S.K., Hampson G. The pathogenesis, diagnosis, investigation and management of osteoporosis. J. Clin. Pathol. 2011;64:1042\u20131050. doi: 10.1136/jcp.2010.077842.", "ArticleIdList": ["10.1136/jcp.2010.077842", "21896577"]}, {"Citation": "Sweet M.G., Sweet J.M., Jeremiah M.P., Salazka S.S. Diagnosis and treatment of osteoporosis. Am. Fam. Phys. 2009;79:193\u2013200.", "ArticleIdList": ["19202966"]}, {"Citation": "Rachner T.D., Khosla S., Hofbauer L.C. Osteoporosis: Now and the future. Lancet. 2011;377:1276\u20131287. doi: 10.1016/S0140-6736(10)62349-5.", "ArticleIdList": ["10.1016/S0140-6736(10)62349-5", "PMC3555696", "21450337"]}, {"Citation": "Hollick R.J., Reid D.M. Role of bisphosphonates in the management of postmenopausal osteoporosis: An update on recent safety anxieties. Menopause Int. 2011;17:66\u201372. doi: 10.1258/mi.2011.011014.", "ArticleIdList": ["10.1258/mi.2011.011014", "21693503"]}, {"Citation": "Park-Wyllie L.Y., Mamdani M.M., Juurlink D.N., Hawker G.A., Gunraj N., Austin P.C., Whelan D.B., Weiler P.J., Laupacis A. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fracture in older women. JAMA. 2011;305:783\u2013789. doi: 10.1001/jama.2011.190.", "ArticleIdList": ["10.1001/jama.2011.190", "21343577"]}, {"Citation": "Lewiecki E.M. Safety of long-term bisphosphonate therapy of the management of osteoporosis. Drugs. 2011;71:791\u2013814. doi: 10.2165/11585470-000000000-00000.", "ArticleIdList": ["10.2165/11585470-000000000-00000", "21504254"]}, {"Citation": "Watts N.B., Diab D.L. Long-term use of bisphosphonates in osteoporosis. J. Clin. Endocrinol. Metab. 2010;95:1555\u20131565. doi: 10.1210/jc.2009-1947.", "ArticleIdList": ["10.1210/jc.2009-1947", "20173017"]}, {"Citation": "Kos M. Bisphosphonates promote jaw osteonecrosis through facilitating bacterial colonization. Med. Hypotheses. 2011;77:214\u2013215. doi: 10.1016/j.mehy.2011.04.015.", "ArticleIdList": ["10.1016/j.mehy.2011.04.015", "21570775"]}, {"Citation": "Knopp-Sihota J.A., Cummings G.G., Homik J., Voaklander D. The association between serious upper gastrointestinal bleeding and incident bisphosphonate use: A population-based nested cohort study. BMC Geriatr. 2013;13:36. doi: 10.1186/1471-2318-13-36.", "ArticleIdList": ["10.1186/1471-2318-13-36", "PMC3653746", "23602075"]}, {"Citation": "Honig S. Osteoporosis, new treatment and updates. Bull. NYU Hosp. Jt. Dis. 2010;68:166\u2013170.", "ArticleIdList": ["20969546"]}, {"Citation": "Silva B.C., Bilezikian J.P. New approaches to the treatment of osteoporosis. Annu. Rev. Med. 2011;62:307\u2013322. doi: 10.1146/annurev-med-061709-145401.", "ArticleIdList": ["10.1146/annurev-med-061709-145401", "21054170"]}, {"Citation": "Bhutani G., Gupta M.C. Emerging therapies for the treatment of osteoporosis. J. Midlife Health. 2013;4:147\u2013152. doi: 10.4103/0976-7800.118991.", "ArticleIdList": ["10.4103/0976-7800.118991", "PMC3952405", "24672186"]}, {"Citation": "Chapurlat R.D. Odanacatib for the treatment of postmenopausal osteoporosis. Expert Opin. Pharmacother. 2014;15:97\u2013102. doi: 10.1517/14656566.2014.853038.", "ArticleIdList": ["10.1517/14656566.2014.853038", "24156249"]}, {"Citation": "Ng K.W., Martin T.J. New therapeutics for osteoporosis. Curr. Opin. Pharmacol. 2014;16:58\u201363. doi: 10.1016/j.coph.2014.03.004.", "ArticleIdList": ["10.1016/j.coph.2014.03.004", "24699340"]}, {"Citation": "Bowring C.E., Francis R.M. National osteoporosis society\u2019s position statement on hormone replacement therapy in the prevention and treatment of osteoporosis. Menopause Int. 2011;17:63\u201365. doi: 10.1258/mi.2011.011012.", "ArticleIdList": ["10.1258/mi.2011.011012", "21693502"]}, {"Citation": "Spangler M., Phillips B.B., Ross M.B., Moores K.G. Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures. Am. J. Health Syst. Pharm. 2011;68:309\u2013318. doi: 10.2146/ajhp070175.", "ArticleIdList": ["10.2146/ajhp070175", "21289325"]}, {"Citation": "Quesada-Gomez J.M., Blanch-Rubio J., Diaz-Curiel M., Diez-Perez A. Calcium citrate and vitamin D in the treatment of osteoporosis. Clin. Drug Investig. 2011;31:285\u2013298. doi: 10.1007/BF03256927.", "ArticleIdList": ["10.1007/BF03256927", "21405146"]}, {"Citation": "Al-Anazi A.F., Qureshi V.F., Javaid K., Qureshi S. Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: An overview. J. Nat. Sci. Biol. Med. 2011;2:154\u2013163.", "ArticleIdList": ["PMC3276006", "22346228"]}, {"Citation": "Taku K., Melby M.K., Nishi N., Omori T., Kurzer M.S. Soy isoflavones for osteoporosis: An evidence-based approach. Maturitas. 2011;70:333\u2013338. doi: 10.1016/j.maturitas.2011.09.001.", "ArticleIdList": ["10.1016/j.maturitas.2011.09.001", "21958941"]}, {"Citation": "Wei P., Liu M., Chen Y., Chen D.C. Systematic review of soy isoflavone supplements on osteoporosis in women. Asian Pac. J. Trop. Med. 2012:243\u2013248. doi: 10.1016/S1995-7645(12)60033-9.", "ArticleIdList": ["10.1016/S1995-7645(12)60033-9", "22305793"]}, {"Citation": "Lagari V.S., Levis S. Phytoestrogens in the prevention of postmenopausal bone loss. J. Clin. Densitom. 2013;16:445\u2013449. doi: 10.1016/j.jocd.2013.08.011.", "ArticleIdList": ["10.1016/j.jocd.2013.08.011", "24090647"]}, {"Citation": "Lagari V.S., Levis S. Phytoestrogens for menopausal bone loss and climacteric symptoms. J. Steroid Biochem. Mol. Biol. 2014;139:294\u2013301. doi: 10.1016/j.jsbmb.2012.12.002.", "ArticleIdList": ["10.1016/j.jsbmb.2012.12.002", "23246986"]}, {"Citation": "Bedell S., Nachtigall M., Naftolin F. The pros and cons of plant estrogens for menopause. J. Steroid Biochem. Mol. Biol. 2014;139:225\u2013236. doi: 10.1016/j.jsbmb.2012.12.004.", "ArticleIdList": ["10.1016/j.jsbmb.2012.12.004", "23270754"]}, {"Citation": "Poluzzi E., Piccinni C., Raschi E., Rampa A., Recanatini M., DePonti F. Phytoestrogens in postmenopause: The state of the art from a chemical, pharmacological and regulatory perspective. Curr. Med. Chem. 2014;21:417\u2013436. doi: 10.2174/09298673113206660297.", "ArticleIdList": ["10.2174/09298673113206660297", "PMC3963458", "24164197"]}, {"Citation": "Putnam S.E., Scutt A.M., Bicknell K., Priestley C.M., Williamson E.M. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother. Res. 2007;21:99\u2013112. doi: 10.1002/ptr.2030.", "ArticleIdList": ["10.1002/ptr.2030", "17106868"]}, {"Citation": "Shirwaikar A., Khan S., Kamariya Y.H., Patel B.D., Gajera F.P. Medicinal plants for the management of post menopausal osteoporosis: A review. Open Bone J. 2010;2:1\u201313. doi: 10.2174/1876525401002010001.", "ArticleIdList": ["10.2174/1876525401002010001"]}, {"Citation": "Wang Z.Q., Li J.L., Sun Y.L., Yao M., Gao J., Yang Z., Shi Q., Cui X.J., Wang Y.J. Chinese herbal medicine for osteoporosis: A systematic review of randomized controlled trials. Evid. Based Complement. Altern. Med. 2013:356260. doi: 10.1155/2013/356260.", "ArticleIdList": ["10.1155/2013/356260", "PMC3572690", "23431336"]}, {"Citation": "Leung P.C., Siu W.S. Herbal treatment for osteoporosis: A current reivew. J. Tradit. Complement. Med. 2013;3:82\u201387. doi: 10.4103/2225-4110.110407.", "ArticleIdList": ["10.4103/2225-4110.110407", "PMC3924968", "24716161"]}, {"Citation": "Li C., Li Q., Liu R., Niu Y., Pan Y., Zhai Y., Mei Q. Medicinal herbs in the prevention and treatment of osteoporosis. Am. J. Chin. Med. 2014;42:1\u201322. doi: 10.1142/S0192415X14500013.", "ArticleIdList": ["10.1142/S0192415X14500013", "24467532"]}, {"Citation": "Mukwaya E., Xu F., Wong M.S., Zhang Y. Chinese herbal medicine for bone health. Pharm. Biol. 2014;52:1223\u20131228. doi: 10.3109/13880209.2014.884606.", "ArticleIdList": ["10.3109/13880209.2014.884606", "24963946"]}, {"Citation": "Liu Y., Liu J.P., Xia Y. Chinese herbal medicines for treating osteoporosis (review) Cochrane Database Syst. Rev. 2014:CD005467.", "ArticleIdList": ["24599707"]}, {"Citation": "Rufus P., Mohamed N., Shuid A.N. Beneficial effects of traditional Chinese medicine on the treatment of osteoporosis on ovariectomised rat models. Curr. Drug Targets. 2015;16:1689\u20131693. doi: 10.2174/1389450114666131220160357.", "ArticleIdList": ["10.2174/1389450114666131220160357", "24354584"]}, {"Citation": "Zhao X., Feng Y., Peng Y. Prevention and treatment of osteoporosis with Chinese herbal medicines. Chin. Herb. Med. 2010;4:265\u2013270."}, {"Citation": "Mukudai Y., Kondo S., Koyama T., Li C., Banka S., Kogure A., Yazawa K., Shintani S. Potential antiosteoporotic effects of herbal extracts on osteoclasts, osteoblasts and chondrocytes in vitro. BMC Complement. Altern. Med. 2014;14:29. doi: 10.1186/1472-6882-14-29.", "ArticleIdList": ["10.1186/1472-6882-14-29", "PMC3904926", "24438322"]}, {"Citation": "Yang Y., Chin A., Zhang L., Lu J., Wong R.W. The role of traditional Chinese medicines in osteogenesis and angiogenisis. Phytother. Res. 2014;28:1\u20138. doi: 10.1002/ptr.4959.", "ArticleIdList": ["10.1002/ptr.4959", "23494901"]}, {"Citation": "Jia M., Nie Y., Cao D.P., Xue Y.Y., Wang J.S., Zhao L., Rahman K., Zhang Q.Y., Qin L.P. Potential antiosteoporotic agents from plants: A comprehensive review. Evid. Based Complement. Altern. Med. 2012:364604. doi: 10.1155/2012/364604.", "ArticleIdList": ["10.1155/2012/364604", "PMC3551255", "23365596"]}, {"Citation": "Lee J., Vasikaran S. Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis. Ann. Lab. Med. 2012;32:105\u2013112. doi: 10.3343/alm.2012.32.2.105.", "ArticleIdList": ["10.3343/alm.2012.32.2.105", "PMC3289774", "22389876"]}, {"Citation": "Seeman E., Delmas P.D. Bone quality\u2014The material and structural basis of bone strength and fragility. N. Engl. J. Med. 2006;354:2250\u20132261. doi: 10.1056/NEJMra053077.", "ArticleIdList": ["10.1056/NEJMra053077", "16723616"]}, {"Citation": "Kanis J.A., McCloskey E.V., Johansson H., Oden A., Melton L.J., Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008;42:467\u2013475. doi: 10.1016/j.bone.2007.11.001.", "ArticleIdList": ["10.1016/j.bone.2007.11.001", "18180210"]}, {"Citation": "Chen H., Zhou X., Fujita H., Onozuka M., Kubo K. Age-related changes in trabecular and cortical bone microstructure. Int. J. Endocrinol. 2013:ID213234. doi: 10.1155/2013/213234.", "ArticleIdList": ["10.1155/2013/213234", "PMC3614119", "23573086"]}, {"Citation": "Wheater G., Elshahaly M., Tuck S.P., Datta H.K., van Laar J.M. The clinical utility of bone marker measurements in osteoporosis. J. Transl. Med. 2013;11:201. doi: 10.1186/1479-5876-11-201.", "ArticleIdList": ["10.1186/1479-5876-11-201", "PMC3765909", "23984630"]}, {"Citation": "Hlaing T.T., Compston J.E. Biochemical markers of bone turnover-uses and limitations. Ann. Clin. Biochem. 2014;51(Pt 2):189\u2013202. doi: 10.1177/0004563213515190.", "ArticleIdList": ["10.1177/0004563213515190", "24399365"]}, {"Citation": "Vasikaran S., Eastell R., Bruyere O., Foldes A.J., Garnero P., Griesmacher A., McClung M., Morris H.A., Silverman S., Trenti T., et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: A need for international reference standards. Ostoporos. Int. 2011;22:391\u2013420. doi: 10.1007/s00198-010-1501-1.", "ArticleIdList": ["10.1007/s00198-010-1501-1", "21184054"]}, {"Citation": "Khashayar P., Meybodi H.A., Amoabediny G., Larijani B. Biochemical markers of bone turnover and their role in osteoporosis diagnosis: A narrative review. Recent Pat. Endocr. Metab. Immune Drug Discov. 2015;9:79\u201389. doi: 10.2174/1872214809666150806105433.", "ArticleIdList": ["10.2174/1872214809666150806105433", "26246012"]}, {"Citation": "Garnero P. New development in biological markers of bone metabolism in osteoporosis. Bone. 2014;66:46\u201355. doi: 10.1016/j.bone.2014.05.016.", "ArticleIdList": ["10.1016/j.bone.2014.05.016", "24909537"]}, {"Citation": "Golub E.E., Boesze-Battaglia K. The role of alkaline phosphatase in mineralization. Curr. Opin. Orthop. 2007;18:444\u2013448. doi: 10.1097/BCO.0b013e3282630851.", "ArticleIdList": ["10.1097/BCO.0b013e3282630851"]}, {"Citation": "Kress B.C. Bone alkaline phosphatase: Methods of quantitation and clinical utility. J. Clin. Ligand Assay. 1998;21:139\u2013148."}, {"Citation": "Halleen J., Tiitinen S., Ylipahkala H., Fagerlund K.M., Vaananen K. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin. Lab. 2006;52:499\u2013509.", "ArticleIdList": ["17078477"]}, {"Citation": "Munoz-Torres M., Reyes-Garcia R., Mezquita-Raya P., Fernandez-Garcia D., Alonso G., de Dios Luna J., Ruiz-Requena M.E., Escobar-Jimenez F. Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate. Maturitas. 2009;64:188\u2013192. doi: 10.1016/j.maturitas.2009.09.011.", "ArticleIdList": ["10.1016/j.maturitas.2009.09.011", "19819089"]}, {"Citation": "Karsenty G., Ferron M. The contribution of bone to whole-organism physiology. Nature. 2012;481:314\u2013320. doi: 10.1038/nature10763.", "ArticleIdList": ["10.1038/nature10763", "22258610"]}, {"Citation": "Jharna S., Nupur S., Purnima D.S., Angoorbala B. Assessment of bone loss in postmenopausal women by evaluation of urinary hydroxyproline and serum status of osteocalcin. Int. Res. J. Biol. Sci. 2013;2:11\u201314."}, {"Citation": "Delmas P.D., Schlemmer A., Gineyts E., Riis B., Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J. Bone Miner. Res. 1991;6:639\u2013644. doi: 10.1002/jbmr.5650060615.", "ArticleIdList": ["10.1002/jbmr.5650060615", "1887826"]}, {"Citation": "Vasikaran S., Cooper C., Eastell R., Griesmacher A., Morris H.A., Trenti T., Kanis J.A. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clin. Chem. Lab Med. 2011;49:1271\u20131274. doi: 10.1515/CCLM.2011.602.", "ArticleIdList": ["10.1515/CCLM.2011.602", "21605012"]}, {"Citation": "Fodor D., Bondor C., Albu A., Simon S.P., Craciun A., Muntean L. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women. J. Invertig. Med. 2013;61:15\u201321.", "ArticleIdList": ["23117696"]}, {"Citation": "Jabbar S., Drury J., Fordham J.N., Datta H.K., Francis R.M., Tuck S.P. Ostoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. J. Clin. Pathol. 2011;64:354\u2013357. doi: 10.1136/jcp.2010.086595.", "ArticleIdList": ["10.1136/jcp.2010.086595", "21307155"]}, {"Citation": "Khosla S. Minireview: The OPG/RANKL/RANK system. Endocrinology. 2001;142:5050\u20135055. doi: 10.1210/endo.142.12.8536.", "ArticleIdList": ["10.1210/endo.142.12.8536", "11713196"]}, {"Citation": "Bauer D., Krege J., Lane N., Leary E., Libanati C., Miller P., Myers G., Silveman S., Vesper H.W., Lee D., et al. National bone health alliance bone turnover marker project: Current practices and the need for us harmonization, standardization, and common reference ranges. Osteoporos. Int. 2012;23:2425\u20132433. doi: 10.1007/s00198-012-2049-z.", "ArticleIdList": ["10.1007/s00198-012-2049-z", "PMC4011662", "22797491"]}, {"Citation": "Kostenuik P.J. Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr. Opin. Pharmacol. 2005;5:618\u2013625. doi: 10.1016/j.coph.2005.06.005.", "ArticleIdList": ["10.1016/j.coph.2005.06.005", "16188502"]}, {"Citation": "Boyce B.F., Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res. Ther. 2007;9(Suupl. 1):S1. doi: 10.1186/ar2165.", "ArticleIdList": ["10.1186/ar2165", "PMC1924516", "17634140"]}, {"Citation": "Kim H.J., Bae Y.C., Park R.W., Choi S.W., Cho S.H., Choi Y.S., Lee W.J. Bone-protecting effect of safflower seeds in ovariectomized rats. Calcif. Tissue Int. 2002;71:88\u201394. doi: 10.1007/s00223-001-1080-4.", "ArticleIdList": ["10.1007/s00223-001-1080-4", "12073158"]}, {"Citation": "Alam M.R., Kim S.M., Lee J.I., Chon S.K., Choi S.J., Choi I.H., Kim N.S. Effects of safflower seed oil in osteoporosis induced-ovariectomized rats. Am. J. Chin. Med. 2006;34:601\u2013612. doi: 10.1142/S0192415X06004132.", "ArticleIdList": ["10.1142/S0192415X06004132", "16883631"]}, {"Citation": "Lee Y.S., Choi C.W., Kim J.J., Ganapathi A., Udayakumar R., Kim S.C. Determination of mineral content in methanolic safflower (Carthamus tinctorius L.) seed extract and its effect on osteoblast markers. Int. J. Mol. Sci. 2009;10:292\u2013305. doi: 10.3390/ijms10010292.", "ArticleIdList": ["10.3390/ijms10010292", "PMC2662456", "19333446"]}, {"Citation": "Jang H.O., Park Y.S., Lee J.H., Seo J.B., Koo K.I., Jeong S.C., Jin S.D., Lee Y.H., Eom H.S., Yun I. Effect of extracts from safflower seeds on osteoblast differentiation and intracellular calcium ion concentration in MC3T3-E1 cells. Nat. Prod. Res. 2007;21:787\u2013797. doi: 10.1080/14786410601133475.", "ArticleIdList": ["10.1080/14786410601133475", "17654282"]}, {"Citation": "Yuk T.H., Kang J.H., Lee S.R., Yuk S.W., Lee K.G., song B.Y., Kim C.H., Kim D.W., Dong I.K., Lee T.K., et al. Inhibitory effects of Carthamus tinctorius L. seed extracts on bone resoprtion medicated by tyrosine kinase, COX-2 (clyclooxygenase) and PG (prostaglandin) E2. Am. J. Chin. Med. 2002;30:95\u2013108. doi: 10.1142/S0192415X02000119.", "ArticleIdList": ["10.1142/S0192415X02000119", "12067102"]}, {"Citation": "Moon H.J., Kim E.K., Nam Y.S., Kim J.H., Ko W.K., Lee J.M., Lee C.H., Jang J.B., Lee K.S., Kwon I.K. Safflower seed extract inhibits osteoclast differentiation by suppression of the p38 mitogen-activated protein kinase and I\u03baB kinase activity. Phytother. Res. 2012;26:1648\u20131655. doi: 10.1002/ptr.4622.", "ArticleIdList": ["10.1002/ptr.4622", "22389167"]}, {"Citation": "Choi S.W., Lee W.J., Park R.W. Use of polyphenol compounds obtained from the seeds of Carthamus tinctorius L. Repub. KR 1020010034963 A 2020060809. Korean Kongkae Taeho Kongbo. 2001 May 7;"}, {"Citation": "Li J.X., Kadota S., Li H.Y., Miyahara T., Wu Y.W., Seto H., Namba T. Effects of Cimicifugae Rhizoma on serum calcium and phosphate levels in low calcium dietary rats and on bone mineral density in ovariectomized rats. Phytomedicine. 1996;3:379\u2013385. doi: 10.1016/S0944-7113(97)80012-8.", "ArticleIdList": ["10.1016/S0944-7113(97)80012-8", "23195197"]}, {"Citation": "Li J.X., Liu J., He C.C., Yu Z.Y., Du Y., Kadota S., Seto H. Triterpenoids from Cimicifugae Rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss. Maturitas. 2007;58:59\u201369. doi: 10.1016/j.maturitas.2007.06.001.", "ArticleIdList": ["10.1016/j.maturitas.2007.06.001", "17658706"]}, {"Citation": "Ahn B.S., Yang M., Jang H., Lee H.J., Moon C., Kim J.C., Jung U., Jo S.K., Jang J.S. Evaulation of the antiosteoporotic potential of Cimicifuga heracleifolia in female mice. Phytother. Res. 2012;26:663\u2013668. doi: 10.1002/ptr.3624.", "ArticleIdList": ["10.1002/ptr.3624", "21987388"]}, {"Citation": "Viereck V., Grundker C., Friess S.C., Frosch K.H., Raddatz D., Schoppet M., Nisslein T., Emons G., Hofbauer L.C. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts. J. Bone Miner. Res. 2005;20:2036\u20132043. doi: 10.1359/JBMR.050716.", "ArticleIdList": ["10.1359/JBMR.050716", "16234977"]}, {"Citation": "Cui G., Leng H., Wang K., Wang J., Zhu S., Jia J., Chen X., Zhang W., Qin L., Bai W. Effects of remifemin treatment on bone integrity and remodeling in rats with ovariectomy-induced osteoporosis. PLoS ONE. 2013;8:e82815. doi: 10.1371/journal.pone.0082815.", "ArticleIdList": ["10.1371/journal.pone.0082815", "PMC3857312", "24349369"]}, {"Citation": "Seidlova-Wuttke D., Stecher G., Kammann M., Haunschild J., Eder N., Stahnke V., Wessels J., Wuttke W. Osteoprotective effects of Cimicifuga racemosa and its triterpene saponins are responsible for reduction of bone marrow fat. Phytomedicine. 2012;19:855\u2013860. doi: 10.1016/j.phymed.2012.05.002.", "ArticleIdList": ["10.1016/j.phymed.2012.05.002", "22739411"]}, {"Citation": "Qiu S.X., Dan C., Ding L.S., Peng S., Chen S.N., Farnsworth N.R., Nolta J., Gross M.L., Zhou P. A triterpene glycoside from black cohosh that inhibits osteoclastogeneisis by modulating RANKL and TNF\u03b1 signaling pathways. Chem. Biol. 2007;14:860\u2013869. doi: 10.1016/j.chembiol.2007.06.010.", "ArticleIdList": ["10.1016/j.chembiol.2007.06.010", "17656322"]}, {"Citation": "Choi E.M. Deoxyactein stimulates osteoblast function and inhibits bone-resorbing mediators in MC3T3-E1 cells. J. Appl. Toxicol. 2013;33:190\u2013195. doi: 10.1002/jat.1733.", "ArticleIdList": ["10.1002/jat.1733", "21910134"]}, {"Citation": "Yamaguchi K., Shinohara C., Kojima S., Sodeoka M., Tsuji T. (2E,6R)-8-Hydroxy-2,6-dimethyl-2-octenoic acid, a novel anti-osteoporotic monoterpene, isolated from Cistanche salsa. Biosci. Biotechnol. Biochem. 1999;63:731\u2013735. doi: 10.1271/bbb.63.731.", "ArticleIdList": ["10.1271/bbb.63.731", "10361686"]}, {"Citation": "Liang H., Yu F., Tong Z., Huang Z. Effect of Cistanches Herba aqueous extract on bone loss in ovariectomized rat. Int. J. Mol. Sci. 2011;12:5060\u20135069. doi: 10.3390/ijms12085060.", "ArticleIdList": ["10.3390/ijms12085060", "PMC3179152", "21954345"]}, {"Citation": "Liang H.D., Yu F., Tong Z.H., Zhang H.Q., Liang W. Cistanches Herba aqueous extract affecting serum BGP and TRAP and bone marrow Smad1 mRNA, Smad5 mRNA, TGF-\u03b21 mRNA and TIEG1 mRNA expression levels in osteoporosis disease. Mol. Biol. Rep. 2013;40:757\u2013763. doi: 10.1007/s11033-012-2065-2.", "ArticleIdList": ["10.1007/s11033-012-2065-2", "23232713"]}, {"Citation": "Li T.M., Huang H.C., Su C.M., Ho T.Y., Wu C.M., Chen W.C., Fong Y.C., Tang C.H. Cistanche deserticola extract increases bone formation in osteoblasts. J. Pharm. Pharmacol. 2012;64:897\u2013907. doi: 10.1111/j.2042-7158.2012.01483.x.", "ArticleIdList": ["10.1111/j.2042-7158.2012.01483.x", "22571269"]}, {"Citation": "Li F., Yang Y., Zhu P., Chen W., Qi D., Shi X., Zhang C., Yang Z., Li P. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. Fitoterapia. 2012;83:1443\u20131450. doi: 10.1016/j.fitote.2012.08.008.", "ArticleIdList": ["10.1016/j.fitote.2012.08.008", "22951288"]}, {"Citation": "Li F., Yang X., Yang Y., Guo C., Zhang C., Yang Z., Li P. Antiosteoporotic activity of echinacoside in ovariectomized rats. Phytomedicine. 2013;20:549\u2013557. doi: 10.1016/j.phymed.2013.01.001.", "ArticleIdList": ["10.1016/j.phymed.2013.01.001", "23428402"]}, {"Citation": "Yang X., Li F., Yang Y., Shen J., Zou R., Zhu P., Zhang C., Yang Z., Li P. Efficacy and safety of echinacoside in a rat osteopenia model. Evid. Based Complement. Altern. Med. 2013:926928. doi: 10.1155/2013/926928.", "ArticleIdList": ["10.1155/2013/926928", "PMC3615573", "23573159"]}, {"Citation": "Mizuha Y., Yamamoto H., Sato T., Tsuji M., Masuda M., Uchida M., Sakai K., Taketani Y., Yasutomo K., Sasaki H., et al. Water extract of Cordyceps sinensis (Wecs) inhibits the RANKL-induced osteoclast differentiation. Biofactors. 2007;30:105\u2013116. doi: 10.1002/biof.5520300204.", "ArticleIdList": ["10.1002/biof.5520300204", "18356582"]}, {"Citation": "Qi W., Yan Y.B., Wang P.J., Lei W. The co-effect of Cordyceps sinensis and strontium on osteoporosis in ovariectomized rats. Biol. Trace Elem. Res. 2011;141:216\u2013223. doi: 10.1007/s12011-010-8711-4.", "ArticleIdList": ["10.1007/s12011-010-8711-4", "20443075"]}, {"Citation": "Qi W., Wang P.J., Guo W.J., Yan Y.B., Zhang Y., Lei W. The mechanism of Cordyceps sinensis and strontium in prevention of osteoporosis in rats. Biol. Trace Elem. Res. 2011;143:302\u2013309. doi: 10.1007/s12011-010-8829-4.", "ArticleIdList": ["10.1007/s12011-010-8829-4", "20803174"]}, {"Citation": "Qi W., Yan Y.B., Lei W., Wu Z.X., Zhang Y., Liu D., Shi L., Cao P.C., Liu N. Prevention of disuse osteoporosis in rats by Cordyceps sinensis extract. Ostoporos. Int. 2012;23:2347\u20132357. doi: 10.1007/s00198-011-1842-4.", "ArticleIdList": ["10.1007/s00198-011-1842-4", "22159671"]}, {"Citation": "Qi W., Zhang Y., Yan Y.B., Lei W., Wu Z.X., Liu N., Liu S., Shi L., Fan Y. The protective effect of cordymin, a peptide purified from the medicinal mushroom Cordyceps sinensis, on diabetic osteopenia in alloxan-induced diabetic rats. Evid. Based Complement. Altern. Med. 2013:985636. doi: 10.1155/2013/985636.", "ArticleIdList": ["10.1155/2013/985636", "PMC3794654", "24174985"]}, {"Citation": "Zhang D.W., Wang Z.L., Qi W., Zhao G.Y. The effects of Cordyceps sinensis phytoestrogen on estrogen deficiency-induced osteoporosis in ovariectomized rats. BMC Complement. Altern. Med. 2014;14:484. doi: 10.1186/1472-6882-14-484.", "ArticleIdList": ["10.1186/1472-6882-14-484", "PMC4302055", "25496560"]}, {"Citation": "Kim J., Lee H., Kang K.S., Chun K.H., Hwang G.S. Cordyceps militaris mushroom and cordycepin inhibit rnakl-induced osteoclast differentiation. J. Med. Food. 2015;18:446\u2013452. doi: 10.1089/jmf.2014.3215.", "ArticleIdList": ["10.1089/jmf.2014.3215", "25789604"]}, {"Citation": "Zhang D.W., Wang Z.L., Qi W., Lei W., Zhao G.Y. Cordycepin (3\u2032-deoxyadenosine) down-regulates the proinflammatory cytokines in inflammation-induced osteoporosis model. Inflammation. 2014;37:1044\u20131049. doi: 10.1007/s10753-014-9827-z.", "ArticleIdList": ["10.1007/s10753-014-9827-z", "24493324"]}, {"Citation": "Yang J., Cao Y., Lv Z., Jiang T., Wang L., Li Z. Cordycepin protected against the TNF-\u03b1-induced inhibition of osteogenic differentiation of human adipose-derived mesenchymal stem cells. Int. J. Immunopathol. Pharmacol. 2015;28:296\u2013307. doi: 10.1177/0394632015592160.", "ArticleIdList": ["10.1177/0394632015592160", "26130747"]}, {"Citation": "Zhang D.W., Deng H., Qi W., Zhao G.Y., Cao X.R. Osteoprotective effect of cordycepin on estrogen deficiency-induced osteoporosis in vitro and in vivo. Biomed. Res. Int. 2015:423869. doi: 10.1155/2015/423869.", "ArticleIdList": ["10.1155/2015/423869", "PMC4385597", "25874211"]}, {"Citation": "Wong R.W.K., Rabie A.B.M., Hagg E.U.O. The effect of crude extract from Radix Dipsaci on bone in mice. Phytother. Res. 2007;21:596\u2013598. doi: 10.1002/ptr.2126.", "ArticleIdList": ["10.1002/ptr.2126", "17380551"]}, {"Citation": "Liu Z.G., Zhang R., Li C., Ma X., Liu L., Wang J.P., Mei Q.B. The osteoprotective effect of Radix Dipsaci extract in ovariectomized rats. J. Ethnopharmacol. 2009;123:74\u201381. doi: 10.1016/j.jep.2009.02.025.", "ArticleIdList": ["10.1016/j.jep.2009.02.025", "19429343"]}, {"Citation": "Niu Y., Li C., Pan Y., Li Y., Kong X., Wang S., Zhai Y., Wu X., Mei Q. Treatment of Radix Dipsaci extract prevents long bone loss induced by modeled microgravity in hindlimb unloading rats. Pharm. Biol. 2015;53:110\u2013116. doi: 10.3109/13880209.2014.911920.", "ArticleIdList": ["10.3109/13880209.2014.911920", "25243871"]}, {"Citation": "Niu Y.B., Li Y.H., Kong X.H., Zhang R., Sun Y., Li Q., Li C., Liu L., Wang J.P., Mei Q.B. The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. Osteoporos. Int. 2012;23:2649\u20132660. doi: 10.1007/s00198-012-1932-y.", "ArticleIdList": ["10.1007/s00198-012-1932-y", "22535190"]}, {"Citation": "Niu Y.B., Kong X.H., Li Y.H., Fan L., Pan Y.L., Li C.R., Wu X.L., Lu T.L., Mei Q.B. Radix Dipsaci total saponins stimulate MC3T3-E1 cell differentiation via the bone morphogenetic protein-2/MAPK/Smad-dependent RUNX2 pathway. Mol. Med. Rep. 2015;11:4468\u20134472.", "ArticleIdList": ["25625570"]}, {"Citation": "Niu Y., Li Y., Huang H., Kong X., Zhang R., Liu L., Sun Y., Wang T., Mei Q. Asperosaponin VI, a saponin component from Dipsacus asper Wall, induces osteoblastic differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway. Phytother. Res. 2011;25:1700\u20131706. doi: 10.1002/ptr.3414.", "ArticleIdList": ["10.1002/ptr.3414", "21452371"]}, {"Citation": "Kim B.S., Kim Y.C., Zadeh H., Park Y.J., Pi S.H., Shin H.S., You H.K. Effects of the dichloromethane fraction of Dipsaci Radix on the osteoblastic differentiation of human alveolar bone marrow-derived mesenchymal stem cells. Biosci. Biotechnol. Biochem. 2011;75:13\u201319. doi: 10.1271/bbb.100379.", "ArticleIdList": ["10.1271/bbb.100379", "21228489"]}, {"Citation": "Jing L.J., Wang C.M., Wei Y.J., Jia X.B., Xie L. Screening on antiosteoporotic active parts of Dipsacus Radix based on zebrafish model. Chin. Herb. Med. (Zhongyaocai) 2014;37:635\u2013640.", "ArticleIdList": ["25345140"]}, {"Citation": "Wang C., Jing L., Wei Y., Jia X. Evaluation of the antiosteoporotic activity of micro-amount asperosaponins V and VI in zebrafish osteoporosis model. J. China Pharm. Univ. (Zhongguo Yaoke Daxue Xuebao) 2014;45:88\u201391."}, {"Citation": "Lin C.Y., Sun J.S., Sheu S.Y., Lin F.H., Wang Y.J., Chen L.T. The effect of Chinese medicine on bone cell activities. Am. J. Chin. Med. 2002;30:271\u2013285. doi: 10.1142/S0192415X02000351.", "ArticleIdList": ["10.1142/S0192415X02000351", "12230016"]}, {"Citation": "Sun J.S., Lin C.Y., Dong G.C., Sheu S.Y., Lin F.H., Chen L.T., Wang Y.L. The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) on bone cell activities. Biomaterials. 2002;23:3377\u20133385. doi: 10.1016/S0142-9612(02)00038-8.", "ArticleIdList": ["10.1016/S0142-9612(02)00038-8", "12099280"]}, {"Citation": "Jeong J.C., Kang S.K., Youn C.H., Jeong C.W., Kim H.M., Lee Y.C., Chang Y.C., Kim C.H. Inhibition of Drynariae Rhizoma extracts on bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts. Int. Immunopharmacol. 2003;3:1685\u20131697. doi: 10.1016/j.intimp.2003.08.003.", "ArticleIdList": ["10.1016/j.intimp.2003.08.003", "14555293"]}, {"Citation": "Shi X.L., Liu K., Wu L.G. Interventional value of total flavonoids from Rhizoma Drynariae on cathepsin K, a potential target of osteoporosis. Chin. J. Integr. Med. 2011;17:556\u2013560. doi: 10.1007/s11655-010-0792-1.", "ArticleIdList": ["10.1007/s11655-010-0792-1", "21725884"]}, {"Citation": "Shi X.L., Li C.W., Wan Q.Z., Li A.Q., Wang H., Liu K. Drynaria total flavonoids decrease cathepsin K expression in ovariectomized rats. Genet. Mol. Res. 2014;13:4311\u20134319. doi: 10.4238/2014.June.9.17.", "ArticleIdList": ["10.4238/2014.June.9.17", "25036175"]}, {"Citation": "Wong R.W., Rabie A.B. Systemic effect of crude extract from rhizome of Drynaria foutunei on bone formation in mice. Phytother. Res. 2006;20:313\u2013315. doi: 10.1002/ptr.1842.", "ArticleIdList": ["10.1002/ptr.1842", "16557621"]}, {"Citation": "Wu H., Chen H., Zhu M. Effects of Drynaria fortunei on bone ultramicrostructure and proline hydroxylation level of ovariectomized rats. Zhongguo Gushang. 2011;24:48\u201350."}, {"Citation": "Lee Y.E., Liu H.C., Lin Y.L., Liu S.H., Yang R.S., Chen R.M. Drynaria fortunei J. Sm. improves the bone mass of ovariectomized rats through osteocalcin-involved endochondral ossification. J. Ethnopharmacol. 2014;158(Pt A):94\u2013101. doi: 10.1016/j.jep.2014.10.016.", "ArticleIdList": ["10.1016/j.jep.2014.10.016", "25456426"]}, {"Citation": "Wang X.L., Wang N.L., Zhang Y., Gao H., Pang W.Y., Wong M.S., Zhang G., Qin L., Yao X.S. Effects of eleven flavonoids from the ostoprotective fraction of Drynaria fortunei (Kunze) J. Sm. on osteoblastic proliferation using an osteoblast-like cell line. Chem. Pharm. Bull. 2008;56:46\u201351. doi: 10.1248/cpb.56.46.", "ArticleIdList": ["10.1248/cpb.56.46", "18175973"]}, {"Citation": "Wang X., Zhen L., Zhang G., Wong M.S., Qin L., Yao X.S. Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei\u2014An in vitro efficacy study. Phytomedicine. 2011;18:868\u2013872. doi: 10.1016/j.phymed.2011.01.022.", "ArticleIdList": ["10.1016/j.phymed.2011.01.022", "21377852"]}, {"Citation": "Wong K.C., Pang W.Y., Wang X.L., Mok S.K., Lai W.P., Chow H.K., Leung P.C., Yao X.S., Wong M.S. Drynaria fortunei-derived flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone. Br. J. Nutr. 2013;110:475\u2013485. doi: 10.1017/S0007114512005405.", "ArticleIdList": ["10.1017/S0007114512005405", "23302510"]}, {"Citation": "Zhang P., Dai K.R., Yan S.G., Yan W.Q., Zhang C., Chen D.Q., Xu B., Xu Z.W. Effects of naringin on the proliferation and osteogenic differentiation of human bone messenchymal stem cell. Eur. J. Pharmacol. 2009;607:1\u20135. doi: 10.1016/j.ejphar.2009.01.035.", "ArticleIdList": ["10.1016/j.ejphar.2009.01.035", "19326565"]}, {"Citation": "Shu X., Liu J., Zhu D., Pang T. Effect of Rhizoma Drynariae total flavonoids on osteogenesis in cultured bone mesenchymal stem cells. Chin. J. Pathol. Physiol. (Zhongguo Bingli Shengli Zashi) 2010;26:1261\u20131264."}, {"Citation": "Chen L.L., Lei L.H., Ding P.H., Tang Q., Wu Y.M. Osteogenic effect of Drynariae rhizoma extracts and naringin on MC3T3-E1 cells and an induced rat alveolar bone resoption model. Arch. Oral. Biol. 2011;56:1655\u20131662. doi: 10.1016/j.archoralbio.2011.06.008.", "ArticleIdList": ["10.1016/j.archoralbio.2011.06.008", "21764032"]}, {"Citation": "Pang W.Y., Wang X.L., Wong K.C., Leung P.C., Yao X.S., Wong M.S. Total flavonoid fraction of Rhizoma Drynaria improves bone properties in ovariectomized mice and exerts estrogen-like activities in rat osteoblast-like (UMR-106) cells. J. Food Drug Anal. 2012;20(Suppl. 1):265\u2013269."}, {"Citation": "Guo Y., Li P.F., Shu X.C., Deng H., Ma H.L., Sun L. Involvement of Wnt/\u03b2-catenin signaling in the osteogenesis of bone marrow mesenchymal stem cells induced by Drynaria total flavonoids. Chin. J. Med. (Zhonghua Yixue Zazhi) 2012;92:2288\u20132291.", "ArticleIdList": ["23158493"]}, {"Citation": "Hung T.Y., Chen T.L., Liao M.H., Ho W.P., Liu D.Z., Chuang W.C., Chen R.M. Drynaria fortunei J. Sm. promotes osteoblast maturation by inducing differentiation-related gene expression and protecting against oxidative stress-induced apoptotic insults. J. Ethnopharmacol. 2010;131:70\u201377. doi: 10.1016/j.jep.2010.05.063.", "ArticleIdList": ["10.1016/j.jep.2010.05.063", "20554009"]}, {"Citation": "Yin F.M., Xiao L.B., Zhang Y. Research progress on Drynaria fortunei naringin on inflammation and bone activity. Chin. Orthop. (Zhongguo Gushang) 2015;28:182\u2013186.", "ArticleIdList": ["25924506"]}, {"Citation": "Wong R.W., Rabie A.B. Effect of naringin on bone cells. J. Orthop. Res. 2006;24:2045\u20132050. doi: 10.1002/jor.20279.", "ArticleIdList": ["10.1002/jor.20279", "16944474"]}, {"Citation": "Wu J.B., Fong Y.C., Tsai H.Y., Chen Y.F., Tsuzuki M., Tang C.H. Naringin-induced bone morphogenetic protein-2 expression via PI3K, AKT, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur. J. Pharmacol. 2008;588:333\u2013341. doi: 10.1016/j.ejphar.2008.04.030.", "ArticleIdList": ["10.1016/j.ejphar.2008.04.030", "18495116"]}, {"Citation": "Ding P., Tang Q., Chen L. Effects of naringin on proliferation, differentiation and matrix mineralization of MC3T3-E1 cells. Chin. J. Chin. Med. (Zhongguo Zhongyao Zazhi) 2009;34:1712\u20131716.", "ArticleIdList": ["19873788"]}, {"Citation": "Pang W.Y., Wang X.L., Mok S.K., Lai W.P., Chow H.K., Leung P.C., Yao X.S., Wong M.S. Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells. Br. J. Pharmacol. 2010;159:1693\u20131703. doi: 10.1111/j.1476-5381.2010.00664.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.00664.x", "PMC2925492", "20397301"]}, {"Citation": "Li N., Jiang Y., Wooley P.H., Xu Z., Yang S.Y. Naringin promotes osteoblast differentiation and effectively reverses ovariectomy-associated osteoporosis. J. Orthop. Res. 2013;18:478\u2013485.", "ArticleIdList": ["23553541"]}, {"Citation": "Zhai Y.K., Niu Y.B., Pan Y.L., Li C.R., Wu X.L., Mei Q.B. Effects of naringin on proliferation, differentiation and maturation of rat calvarial osteoblasts in vitro. Chin. J. Chin. Med. (Zhongguo Zhongyao Zazhi) 2013;38:105\u2013111.", "ArticleIdList": ["23596885"]}, {"Citation": "Liu M., Li Y., Yang S.T. Effects of naringin on the proliferation and osteogenic differentiation of human amniotic fluid-derived stem cells. J. Tissue Eng. Regen. Med. 2014 doi: 10.1002/term.1911.", "ArticleIdList": ["10.1002/term.1911", "24915843"]}, {"Citation": "Yin L., Cheng W., Qin Z., Yu H., Yu Z., Zhong M., Sun K., Zhang W. Effects of naringin on proliferation and osteogenic differentiation of human periodontal ligament stem cells in vitro and in vivo. Stem Cell Int. 2015:758706. doi: 10.1155/2015/758706.", "ArticleIdList": ["10.1155/2015/758706", "PMC4452874", "26078764"]}, {"Citation": "Fan J., Li J., Fan Q. Naringin promotes differentiation of bone marrow stem cells into osteoblasts by upregulating the expression levels of microrRNA-20a and downregulating the expression levels of PPAR\u03b3. Mol. Med. Rep. 2015;12:4759\u20134765.", "ArticleIdList": ["26126997"]}, {"Citation": "Cao X., Lin W., Liang C., Zhang D., Yang F., Zhang Y., Zhang X., Feng J.Q., Chen C. Naringin rescued the TNF-\u03b1-induced inhibition of osteogenesis of bone marrow-derived mesenchymal stem cells by depressing the activation of NF-\u03baB signaling pathway. Immunol. Res. 2015;62:357\u2013367. doi: 10.1007/s12026-015-8665-x.", "ArticleIdList": ["10.1007/s12026-015-8665-x", "26032685"]}, {"Citation": "Yu X., Zhao X., Wu T., Zhou Z., Gao Y., Wang X., Zhang C.Q. Inhibiting wear particles-induced osteolysis with naringin. Int. Orthop. 2013;37:137\u2013143. doi: 10.1007/s00264-012-1668-5.", "ArticleIdList": ["10.1007/s00264-012-1668-5", "PMC3532638", "23111634"]}, {"Citation": "Li F.B., Sun X.L., Ma J.X., Zhang Y., Zhao B., Li Y.L., Ma X.L. Effect of naringin on osteoclast differentiation. Chin. J. Chin. Med. (Zhongguo Zhongyao Zazhi) 2015;40:308\u2013312.", "ArticleIdList": ["26080564"]}, {"Citation": "Ang E.S., Yang X., Chen H., Liu Q., Zheng M.H., Xu J. Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-\u03baB and ERK activation. FEBS Lett. 2011;585:2755\u20132762. doi: 10.1016/j.febslet.2011.07.046.", "ArticleIdList": ["10.1016/j.febslet.2011.07.046", "21835177"]}, {"Citation": "Li F., Sun X., Ma J., Ma X., Zhao B., Zhang Y., Tian P., Li Y., Han Z. Naringin prevents ovariectomy-induced osteoporosis and promotes osteoclasts apoptosis through the mitochondria-medicated apoptosis pathway. Biochem. Biophys. Res. Commun. 2014;452:629\u2013635. doi: 10.1016/j.bbrc.2014.08.117.", "ArticleIdList": ["10.1016/j.bbrc.2014.08.117", "25181344"]}, {"Citation": "Wei M., Yang Z., Li P., Zhang Y., See W.C. Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model. Am. J. Chin. Med. 2007;35:663\u2013667. doi: 10.1142/S0192415X07005156.", "ArticleIdList": ["10.1142/S0192415X07005156", "17708632"]}, {"Citation": "Mandadi K., Ramirez M., Jayaprakasha G.K., Faraji B., Lihono M., Deyhim F., Patil B.S. Citrus bioactive compounds improve bone qualtiy and plasma antioxidant activity in orchidectomized rats. Phytomedicine. 2009;16:513\u2013520. doi: 10.1016/j.phymed.2008.09.001.", "ArticleIdList": ["10.1016/j.phymed.2008.09.001", "18930642"]}, {"Citation": "Habauzit V., Sacco S.M., Gil-Izquierdo A., Trzeciakiewicz A., Morand C., Barron D., Pinaud S., Offord E., Horcajada M.N. Differential effects of two citrus flavanones on bone quality in senescent male rats in relation to their bioavailability and metabolism. Bone. 2011;49:1108\u20131116. doi: 10.1016/j.bone.2011.07.030.", "ArticleIdList": ["10.1016/j.bone.2011.07.030", "21820093"]}, {"Citation": "Zhou X., Zhang P., Zhang C., Zhu Z. Promotion of bone formation by naringin in a titanium particle-induced diabetic murine calvarial osteolysis model. J. Orthop. Res. 2010;28:451\u2013456. doi: 10.1002/jor.21002.", "ArticleIdList": ["10.1002/jor.21002", "19824055"]}, {"Citation": "Wong R.W., Rabie A.B. Effect of naringin collagen graft on bone formation. Biomaterials. 2006;27:1824\u20131831. doi: 10.1016/j.biomaterials.2005.11.009.", "ArticleIdList": ["10.1016/j.biomaterials.2005.11.009", "16310246"]}, {"Citation": "Chen K.Y., Lin K.C., Chen Y.S., Yao C.H. A novel porous gelatin composite containing naringin for bone repair. Evid. Based Complement. Altern. Med. 2013:283941. doi: 10.1155/2013/283941.", "ArticleIdList": ["10.1155/2013/283941", "PMC3575669", "23431335"]}, {"Citation": "Ji Y., Wang L., Watts D.C., Qiu H., You T., Deng F., Wu X. Controlled-release naringin nanoscaffold for osteoporotic bone healing. Dent. Mater. 2014;30:1263\u20131273. doi: 10.1016/j.dental.2014.08.381.", "ArticleIdList": ["10.1016/j.dental.2014.08.381", "25238705"]}, {"Citation": "Li N., Xu Z., Wooley P.H., Zhang J., Yang S.Y. Therapeutic potentials of naringin on polymethylmethacrylate induced osteoclastogenesis and osteolysis, in vitro and in vivo assessments. Drug Des. Devel. Ther. 2014;8:1\u201311.", "ArticleIdList": ["PMC3864877", "24376342"]}, {"Citation": "Li N.H., Xu Z.W. Naringin reduced polymethylmethacrylate-induced osteolysis in the mouse air sacs model. Chin. Orthop. (Zhongguo Gushang) 2015;28:345\u2013349.", "ArticleIdList": ["26072618"]}, {"Citation": "Kang S.N., Lee J.S., Park J.H., Cho J.H., Park J.H., Cho K.K., Lee O.H., Kim I.S. In vitro anti-osteoporosis properties of diverse Korean Drynariae Rhizoma phenolic extracts. Nutrients. 2014;6:1737\u20131751. doi: 10.3390/nu6041737.", "ArticleIdList": ["10.3390/nu6041737", "PMC4011064", "24763116"]}, {"Citation": "Chen H.Y., Lin Y.H., Wu J.C., Chen Y.C., Yang S.H., Chen J.L., Chen T.J. Prescription patterns of Chinese herbal products for menopausal syndrome: Analysis of a nationwide preseciption database. J. Ethnopharmacol. 2011;137:1261\u20131266. doi: 10.1016/j.jep.2011.07.053.", "ArticleIdList": ["10.1016/j.jep.2011.07.053", "21824510"]}, {"Citation": "Lee M.K., Ha N.R., Yang H., Sung S.H., Kim Y.C. Simulatory constituents of Eclipta prostrata on mouse osteoblast differentiation. Phytother. Res. 2009;23:129\u2013131. doi: 10.1002/ptr.2560.", "ArticleIdList": ["10.1002/ptr.2560", "18683850"]}, {"Citation": "Lin X.H., Wu Y.B., Lin S., Zeng J.W., Zeng P.Y., Wu J.Z. Effects of volatile components and ethanolic extract from Eclipta prostrata on proliferation and differentiation of primary osteoblasts. Molecules. 2010;15:241\u2013250. doi: 10.3390/molecules15010241.", "ArticleIdList": ["10.3390/molecules15010241", "PMC6257114", "20110887"]}, {"Citation": "Zhang Z.G., Bai D., Liu M.J., Li Y., Pan J.H., Liu H., Wang W.L., Xiang L.H., Xiao G.G., Ju D.H. Therapeutic effect of aqueous extract from Ecliptae Herba on bone metabolism of ovariectomized rats. Menopause. 2013;20:232\u2013240. doi: 10.1097/gme.0b013e318265e7dd.", "ArticleIdList": ["10.1097/gme.0b013e318265e7dd", "23096243"]}, {"Citation": "Joh E.H., Gu W., Kim D.H. Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-\u03baB and MAPK pathways. Biochem. Pharmacol. 2012;84:331\u2013240. doi: 10.1016/j.bcp.2012.04.020.", "ArticleIdList": ["10.1016/j.bcp.2012.04.020", "22564908"]}, {"Citation": "Ryu S., Shin J.S., Jung J.Y., Cho Y.W., Kim S.J., Jang D.S., Lee K.T. Echinocystic acid isolated from Eclipta prostrata suppresses lipopolysaccharide-induced iNOS, TNF-\u03b1, and IL-6 expressions via NF-\u03baB inactivation in RAW 264.7 macrophages. Planta Med. 2013;79:1031\u20131037. doi: 10.1055/s-0032-1328767.", "ArticleIdList": ["10.1055/s-0032-1328767", "23877917"]}, {"Citation": "Wang H., Wang Q., Xiao S.L., Yu F., Ye M., Zheng Y.X., Zhao C.K., Sun D.A., Zhang L.H., Zhou D.M. Elucidation of the pharmacophore of echinocystic acid, a new lead for blocking HCV entry. Eur. J. Med. Chem. 2013;64:160\u2013168. doi: 10.1016/j.ejmech.2013.03.041.", "ArticleIdList": ["10.1016/j.ejmech.2013.03.041", "23644199"]}, {"Citation": "Deng Y.T., Kang W.B., Zhao J.N., Liu G., Zhao M.G. Osteoprotective effect of echinocystic acid, a triterpone component from Eclipta prostrata, in ovariectomy-induced osteoporotic rats. PLoS ONE. 2015;10:e0136572. doi: 10.1371/journal.pone.0136572.", "ArticleIdList": ["10.1371/journal.pone.0136572", "PMC4552887", "26317835"]}, {"Citation": "Liu Y.Q., Zhan L.B., Liu T., Cheng M.C., Liu X.Y., Xiao H.B. Inhibitory effect of Ecliptae Herba extract and its component wedelolactone on pre-osteoclastic proliferation and differentiation. J. Ethnopharmacol. 2014;157:206\u2013211. doi: 10.1016/j.jep.2014.09.033.", "ArticleIdList": ["10.1016/j.jep.2014.09.033", "25267578"]}, {"Citation": "Zhai Y.K., Guo X., Pan Y.L., Niu Y.B., Li C.R., Wu X.L., Mei Q.B. A systematic review of the efficacy and pharmacological profile of Herba Epimedii in osteoporosis therapy. Pharmazie. 2013;68:713\u2013722.", "ArticleIdList": ["24147339"]}, {"Citation": "Wu H., Lien E.J., Lien L.L. Chemical and pharmacological investigations of Epimedium species: A survey. Prog. Drug Res. 2003;60:1\u201357.", "ArticleIdList": ["12790338"]}, {"Citation": "Zhang G., Qin L., Hung W.Y., Shi Y.Y., Leung P.C., Yeung H.Y., Leung K.S. Flavonoids derived from herbal Epimedium brevicornum Maxim. Prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. Bone. 2006;38:818\u2013825. doi: 10.1016/j.bone.2005.11.019.", "ArticleIdList": ["10.1016/j.bone.2005.11.019", "16413840"]}, {"Citation": "Songlin P., Ge Z., Yixin H., Xinluan W., Pingchung L., Kwoksui L., Ling Q. Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on osteoporotic bone. Bone. 2009;45:534\u2013544.", "ArticleIdList": ["19501202"]}, {"Citation": "Xu Y.X., Wu C.L., Wu Y., Tong P.J., Jin H.T., Yu N.Z., Xiao L.W. Epimedium-derived flavonoids modulate the balance between osteogenic differentiation and adipogenic differentiation in bone marrow stromal cells of ovariectomized rats via Wnt/\u03b2-catenin signal pathway activation. Chin. J. Integr. Med. 2012;18:909\u2013917. doi: 10.1007/s11655-012-1294-2.", "ArticleIdList": ["10.1007/s11655-012-1294-2", "23238999"]}, {"Citation": "Zhang G., Qin L., Shi Y. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: A 24-month randomized, double-blind and placebo-controlled trial. J. Bone Miner. Res. 2007;22:1072\u20131079. doi: 10.1359/jbmr.070405.", "ArticleIdList": ["10.1359/jbmr.070405", "17419678"]}, {"Citation": "Ming L.G., Chen K.M., Xian C.J. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. J. Cell. Physiol. 2013;228:513\u2013521. doi: 10.1002/jcp.24158.", "ArticleIdList": ["10.1002/jcp.24158", "22777826"]}, {"Citation": "Li C., Li Q., Mei Q., Lu T. Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii. Life Sci. 2015;126:57\u201368. doi: 10.1016/j.lfs.2015.01.006.", "ArticleIdList": ["10.1016/j.lfs.2015.01.006", "25634110"]}, {"Citation": "Yang L., Yu Z., Qu H., Li M. Comparative effects of hispidulin, genistein, and icariin with estrogen on bone tissue in ovariectomized rats. Cell. Biochem. Biophys. 2014;70:485\u2013490. doi: 10.1007/s12013-014-9945-0.", "ArticleIdList": ["10.1007/s12013-014-9945-0", "24748177"]}, {"Citation": "Nian H., Ma M.H., Nian S.S., Xu L.L. Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine. 2009;16:320\u2013326. doi: 10.1016/j.phymed.2008.12.006.", "ArticleIdList": ["10.1016/j.phymed.2008.12.006", "19269147"]}, {"Citation": "Liu M., Zhong C., He R.X., Chen L.F. Icariin associated with exercise therapy is an effective treatment for postmenopausal osteoporosis. Chin. Med. J. (Engl. Ed.) 2012;125:1784\u20131789.", "ArticleIdList": ["22800900"]}, {"Citation": "Mok S.K., Chen W.F., Lai W.P., Leung P.C., Wang X.L., Yao X.S., Wong M.S. Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br. J. Pharmacol. 2010;159:939\u2013949. doi: 10.1111/j.1476-5381.2009.00593.x.", "ArticleIdList": ["10.1111/j.1476-5381.2009.00593.x", "PMC2829219", "20128811"]}, {"Citation": "Bian Q., Huang J.H., Liu S.F., Ning Y., Yang A., Zhao Y.J., Shen Z.Y., Wang Y.J. Different molecular targets of icariin on bMSCs in CORT and OVX-rats. Front. Biosci. (Elite Ed.) 2012;4:1224\u20131236. doi: 10.2741/E453.", "ArticleIdList": ["10.2741/E453", "22201948"]}, {"Citation": "Li G.W., Xu Z., Chang S.X., Nian H., Wang X.Y., Qin L.D. Icariin prevents ovariectomy-induced bone loss and lowers marrow adipogenesis. Menopause. 2014;21:1007\u20131016. doi: 10.1097/GME.0000000000000201.", "ArticleIdList": ["10.1097/GME.0000000000000201", "24552978"]}, {"Citation": "Feng R., Feng L., Yuan Z., Wang D., Wang F., Tan B., Han S., Li T., Li D., Han Y. Icariin protects against glucocorticoid-induced osteoporosis in vivo and prevents glucocorticoid-induced osteocyte apoptosis in vitro. Cell. Biochem. Biophys. 2013;67:189\u2013197. doi: 10.1007/s12013-013-9533-8.", "ArticleIdList": ["10.1007/s12013-013-9533-8", "23417569"]}, {"Citation": "Zhang J., Song J., Shao J. Icariin attenuates glucocorticoid-induced bone deteriorations, hypocalcemia and hypercalciuria in mice. Int. J. Clin. Exp. Med. 2015;8:7306\u20137314.", "ArticleIdList": ["PMC4509215", "26221270"]}, {"Citation": "Zheng D., Peng S., Yang S.H., Shao Z.W., Yang C., Feng Y., Wu W., Zhen W.X. The beneficial effect of icariin on bone is diminished in osteoprotegerin-deficient mice. Bone. 2012;51:85\u201392. doi: 10.1016/j.bone.2012.04.006.", "ArticleIdList": ["10.1016/j.bone.2012.04.006", "22551876"]}, {"Citation": "Li X.F., Xu H., Zhao Y.J., Tang D.Z., Xu G.H., Holz J., Wang J., Cheng S.D., Shi Q., Wang Y.J. Icariin augments bone formation and reverses the phenotypes of osteoprotegerin-deficient mice through the activation of Wnt/\u03b2-catenin-BMP signaling. Evid. Based Complement. Altern. Med. 2013:652317. doi: 10.1155/2013/652317.", "ArticleIdList": ["10.1155/2013/652317", "PMC3835354", "24348713"]}, {"Citation": "Zhai Y.K., Guo X.Y., Ge B.F., Zhen P., Ma X.N., Zhou J., Ma H.P., Xian C.J., Chen K.M. Icariin stimulates the osteogenic differentiation of rat bone marrow stromal cells via activating the PI3K-AKT-eNOS-NO-cGMP-PKG. Bone. 2014;66:189\u2013198. doi: 10.1016/j.bone.2014.06.016.", "ArticleIdList": ["10.1016/j.bone.2014.06.016", "24956021"]}, {"Citation": "Luo Z., Liu M., Sun L., Rui F. Icariin recovers the osteogenic differentiation and bone formation of bone marrow stromal cells from a rat model of estrogen deficiency-induced osteoporosis. Mol. Med. Rep. 2015;12:382\u2013388. doi: 10.3892/mmr.2015.3369.", "ArticleIdList": ["10.3892/mmr.2015.3369", "25695835"]}, {"Citation": "Meng F.H., Li Y.B., Xiong Z.L., Jiang Z.M., Li F.M. Osteoblastic proliferative activity of Epimedium brevicornuim Maxim. Phytomedicine. 2005;12:189\u2013193. doi: 10.1016/j.phymed.2004.03.007.", "ArticleIdList": ["10.1016/j.phymed.2004.03.007", "15830840"]}, {"Citation": "Fan J.J., Cao L.G., Wu T., Wang D.X., Jin D., Jiang S., Zhang Z.Y., Bi L., Pei G.X. The dose-effect of icariin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cells. Molecules. 2011;16:10123\u201310133. doi: 10.3390/molecules161210123.", "ArticleIdList": ["10.3390/molecules161210123", "PMC6264195", "22146373"]}, {"Citation": "Yin X.X., Chen Z.Q., Liu Z.L., Ma Q.J., Dang G.T. Icariin stimulates proliferation and differentiation of human osteoblasts by increasing production of bone morphogenetic protein 2. Chin. Med. J. (Engl. Ed.) 2007;120:204\u2013210.", "ArticleIdList": ["17355822"]}, {"Citation": "Hsieh T.P., Sheu S.Y., Sun J.S., Chen M.H., Liu M.H. Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression. Phytomedicine. 2010;17:414\u2013423. doi: 10.1016/j.phymed.2009.08.007.", "ArticleIdList": ["10.1016/j.phymed.2009.08.007", "19747809"]}, {"Citation": "Zhao J., Ohba S., Komiyama Y., Shinkai M., Chung U.I., Nagamune T. Icariin: A potential osteoinductive compound for bone tissue engineering. Tissue Eng. (Part A) 2010;16:233\u2013243. doi: 10.1089/ten.tea.2009.0165.", "ArticleIdList": ["10.1089/ten.tea.2009.0165", "19698057"]}, {"Citation": "Ma H.P., Ming L.G., Ge B.F., Zhai Y.K., Song P., Xian C.J., Chen K.M. Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J. Cell Biochem. 2011;112:916\u2013923. doi: 10.1002/jcb.23007.", "ArticleIdList": ["10.1002/jcb.23007", "21328465"]}, {"Citation": "Cao H., Ke Y., Zhang Y., Zhang C.J., Qian W., Zhang G.L. Icariin stimulates MC3T3-E1 cell proliferation and differentiation through up-regulation of bone morphogenetic protein-2. Int. J. Mol. Med. 2012;29:435\u2013439.", "ArticleIdList": ["22109711"]}, {"Citation": "Liang W., Lin M., Li X., Li C., Gao B., Gan H., Yang Z., Lin X., Liao L., Yang M. Icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line. Int. J. Mol. Med. 2012;30:889\u2013895.", "ArticleIdList": ["22842877"]}, {"Citation": "Zhao J., Ohba S., Shinkai M., Chung U.I., Nagamune T. Icariin induces osteogenic differentiation in vitro in a BMP- and RUNX2-dependent manner. Biochem. Biophys. Res. Commun. 2008;369:444\u2013448. doi: 10.1016/j.bbrc.2008.02.054.", "ArticleIdList": ["10.1016/j.bbrc.2008.02.054", "18295595"]}, {"Citation": "Ma X.N., Ge B.F., Chen K.M., Zhou J., Shi W.G., Xie Y.F., Guo X.Y., Lv X., Cheng K., Gao Y.H. Mechanisms of icariin in regulatng bone formation of osteoblasts and bone resorption of osteoclasts. J. Chin. Acad. Med. Sci. (Zhongguo Yixue Kexue Yuan Xuebao) 2013;35:432\u2013438.", "ArticleIdList": ["23987492"]}, {"Citation": "Ma X.N., Zhou J., Ge B.F., Zhen P., Ma H.P., Shi W.G., Cheng K., Xian C.J., Chen K.M. Icariin induces osteoblast differentiation and mineralization without dexamethasone in vitro. Planta Med. 2013;79:1501\u20131508. doi: 10.1055/s-0033-1350802.", "ArticleIdList": ["10.1055/s-0033-1350802", "24072503"]}, {"Citation": "Xiao H.H., Fung C.Y., Mok S.K., Wong K.C., Ho M.X., Wang X.L., Yao X.S., Wong M.S. Flavonoids from Herba Epimedii selectively activate estrogen receptor \u03b1 and stimulate ER-dependent osteoblastic functions in UMR-106 cells. J. Steroid Biochem. Mol. Biol. 2014;143:141\u2013151. doi: 10.1016/j.jsbmb.2014.02.019.", "ArticleIdList": ["10.1016/j.jsbmb.2014.02.019", "24607839"]}, {"Citation": "Song L., Zhao J., Zhang X., Li H., Zhou Y. Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation. Eur. J. Pharmacol. 2013;714:15\u201322. doi: 10.1016/j.ejphar.2013.05.039.", "ArticleIdList": ["10.1016/j.ejphar.2013.05.039", "23764463"]}, {"Citation": "Wang Z., Ding L., Zhang S., Jiang T., Yang Y., Li R. Effects of icariin on the regulation of the OPG-RANKL-RANK system are mediated through the MAPK pathways in IL-1\u03b2-stimulated human SW1353 chondrosarcoma cells. Int. J. Mol. Med. 2014;34:1720\u20131726. doi: 10.3892/ijmm.2014.1952.", "ArticleIdList": ["10.3892/ijmm.2014.1952", "25270538"]}, {"Citation": "Wu Y., Xia L., Zhou Y., Xu Y., Jiang X. Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner. Cell Prolif. 2015;48:375\u2013384. doi: 10.1111/cpr.12185.", "ArticleIdList": ["10.1111/cpr.12185", "PMC6496185", "25867119"]}, {"Citation": "Bian Q., Huang J.H., Yang Z., Ning Y., Zhao Y.J., Wang Y.J., Shen Z.Y. Effects of active ingredients in three kidney-tonifying chinese herbal drugs on gene expression profile of bone marrow stromal cells from a rat model of corticosterone-induced osteoporosis. Integr. Chin. West. Med. (Zhong Xi Yi Jie He Xuebao) 2011;9:179\u2013185. doi: 10.3736/jcim20110211.", "ArticleIdList": ["10.3736/jcim20110211", "21288454"]}, {"Citation": "Ma H.P., Ma X.N., Ge B.F., Zhen P., Zhou J., Gao Y.H., Xian C.J., Chen K.M. Icariin attenuates hypoxia-induced oxidative stress and apoptosis in osteoblasts and preserves their osteogenic differentiation potential in vitro. Cell Prolif. 2014;47:527\u2013539. doi: 10.1111/cpr.12147.", "ArticleIdList": ["10.1111/cpr.12147", "PMC6496789", "25355404"]}, {"Citation": "Sun Z.B., Wang J.W., Xiao H., Zhang Q.S., Kan W.S., Mo F.B., Hu S., Ye S.N. Icariin may benefit the mesenchymal stem cells of patients with steroid-associated osteonecrosis by ABCB1-promoter demethylation: A preliminary study. Osteoporos. Int. 2015;26:187\u2013197. doi: 10.1007/s00198-014-2809-z.", "ArticleIdList": ["10.1007/s00198-014-2809-z", "25112719"]}, {"Citation": "Zhang X., Liu T., Huang Y., Wismeijer D., Liu Y. Icariin: Does it have an osteoinductive potential for bone tissue engineering? Phytother. Res. 2014;28:498\u2013509. doi: 10.1002/ptr.5027.", "ArticleIdList": ["10.1002/ptr.5027", "23824956"]}, {"Citation": "Zhang X., Guo Y., Li D.X., Wang R., Fan H.S., Xiao Y.M., Zhang L., Zhang X.D. The effect of loading icariin on biocompatibiltiy and bioactivity of porous \u03b2-TCP ceramic. J. Mater. Sci.: Matr. Med. 2011;22:371\u2013379.", "ArticleIdList": ["21140197"]}, {"Citation": "Xie X., Pei F., Wang H., Tan Z., Yang Z., Kang P. Icariin: A promising osteoinductive compound for repairing bone defect and osteonecrosis. J. Biomater. Appl. 2015;30:290\u2013299. doi: 10.1177/0885328215581551.", "ArticleIdList": ["10.1177/0885328215581551", "25876888"]}, {"Citation": "Xia J., Li Y., Zhou Z., Dai Y., Liu H., Liu H. Icariin delivery porous phbv scaffolds for pormoting osteoblast expansion in vitro. Mater. Sci. Eng. 2013;33:3545\u20133552. doi: 10.1016/j.msec.2013.04.050.", "ArticleIdList": ["10.1016/j.msec.2013.04.050", "23706245"]}, {"Citation": "Cui J., Zhu M., Zhu S., Wang G., Xu Y., Geng D. Inhibitory effect of icariin on Ti-induced inflammatory osteoclastogenesis. J. Surg. Res. 2014;192:447\u2013453. doi: 10.1016/j.jss.2014.05.038.", "ArticleIdList": ["10.1016/j.jss.2014.05.038", "24969548"]}, {"Citation": "Shao H., Shen J., Wang M., Cui J., Wang Y., Zhu S., Zhang W., Yang H., Xu Y., Geng D. Icariin protects against titanium particle-induced osteolysis and inflammatory response in a mouse calvarial model. Biomaterials. 2015;60:92\u201399. doi: 10.1016/j.biomaterials.2015.04.048.", "ArticleIdList": ["10.1016/j.biomaterials.2015.04.048", "25985156"]}, {"Citation": "Wang Z.C., Sun H.J., Li K.H., Fu C., Liu M.Z. Icariin promotes directed chondrogenic differentiation of bone marrow messenchymal stem cells but not hypertrophy in vitro. Exp. Ther. Med. 2014;8:1528\u20131534.", "ArticleIdList": ["PMC4186337", "25289054"]}, {"Citation": "Li D., Yuan T., Zhang X., Xiao Y., Wang R., Fan Y., Zhang X. Icariin: A potential promoting compound for cartilage tissue engineering. Osteoarthr. Cartil. 2012;20:1647\u20131656. doi: 10.1016/j.joca.2012.08.009.", "ArticleIdList": ["10.1016/j.joca.2012.08.009", "22917745"]}, {"Citation": "Huang J.G., Pang L., Chen Z.R., Tan X.P. Dual-delivery of vanacomycin and icariin from an injectable calcium phosphate cement-release system for controlling infection and improving bone healing. Mol. Med. Rep. 2013;8:1221\u20131227.", "ArticleIdList": ["23933682"]}, {"Citation": "Wang Q.S., Zhang X.C., Li R.X., Sun J.G., Su W.H., Guo Y., Li H., Zhang X.Z. A comparative study of mechanical strain, icariin and combination stimulations on improving osteoinductive potential via NF-\u03baB activation in osteoblast-like cells. Biomed. Eng. Online. 2015;14:46. doi: 10.1186/s12938-015-0039-z.", "ArticleIdList": ["10.1186/s12938-015-0039-z", "PMC4455701", "25994935"]}, {"Citation": "Xue L., Jiao L., Wang Y., Nie Y., Han T., Jiang Y., Rahman K., Zhang Q., Qin L. Effects and interaction of icariin, curculigoside, and berberine in Er-Xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption. Evid. Based Complement. Altern. Med. 2012:490843. doi: 10.1155/2012/490843.", "ArticleIdList": ["10.1155/2012/490843", "PMC3519276", "23243450"]}, {"Citation": "Xue L., Wang Y., Jiang Y., Han T., Nie Y., Zhao L., Zhang Q., Qin L. Comparative effects of Er-Xian decoction, Epimedium herbs, and icariin with estrogen on bone and reproductive tissue in ovariectomized rats. Evid. Based Complement. Altern. Med. 2012:241416. doi: 10.1155/2012/241416.", "ArticleIdList": ["10.1155/2012/241416", "PMC3511842", "23227099"]}, {"Citation": "Chen K.M., Ge B.F., Liu X.Y., Ma P.H., Lu M.B., Bai M.H., Wang Y. Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Pharmazie. 2007;62:388\u2013391.", "ArticleIdList": ["17557750"]}, {"Citation": "Huang J., Yuan L., Wang X., Zhang T.L., Wang K. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro. Life Sci. 2007;81:832\u2013840. doi: 10.1016/j.lfs.2007.07.015.", "ArticleIdList": ["10.1016/j.lfs.2007.07.015", "17764702"]}, {"Citation": "Hsieh T.P., Sheu S.Y., Sun J.S., Chen M.H. Icariin inhibits osteoblast differentiation and bone resoprtion by suppression of MAPKs/NF-\u03baB regulated HIF-1\u03b1 and PGE(2) synthesis. Phytomedicine. 2011;18:176\u2013185. doi: 10.1016/j.phymed.2010.04.003.", "ArticleIdList": ["10.1016/j.phymed.2010.04.003", "20554188"]}, {"Citation": "Wang R., Luo J.G., Kong L.Y. An MC3T3-E1 cell line biomembrane extraction and HPLC-ESI-MSn method for simultaneous analysis of potential anti-osteoporosis components of Eipmedium koreanum. Chromatographia. 2012;75:607\u2013615. doi: 10.1007/s10337-012-2232-6.", "ArticleIdList": ["10.1007/s10337-012-2232-6"]}, {"Citation": "Zhan Y., Wei Y.J., Sun E., Xu F.J., Jia X.B. Two-dimensional zebrafish model combined with hyphenated chromatographic techniques for evaluation of antiosteoporosis activity of epimedin A and its metabolite baohuoside. Acta Pharm. Sin. (Yaoxue Xuebao) 2014;49:932\u2013937.", "ArticleIdList": ["25212043"]}, {"Citation": "Zhang D.W., Zhang J., Fong C., Yao X.S., Yang M. Herba Epimedii flavonoids suppress osteoclastic differentiation and bone resoption by inducing G2/M arrest and apoptosis. Biochimie. 2012;94:2514\u20132522. doi: 10.1016/j.biochi.2012.06.033.", "ArticleIdList": ["10.1016/j.biochi.2012.06.033", "22796380"]}, {"Citation": "Yang L., Wang N.L., Cai G.P. Maohuoside a promotes osteogenesis of rat mesenchymal stem cells via BMP and MAPK signaling pathways. Mol. Cell. Biochem. 2011;358:37\u201344. doi: 10.1007/s11010-011-0918-y.", "ArticleIdList": ["10.1007/s11010-011-0918-y", "21698346"]}, {"Citation": "Cai M., Li G., Tao K., Yang Y., Lou L., Cai Z., Yu Y. Maohuoside a acts in a BMP-dependent manner during osteogenesis. Phytother. Res. 2013;27:1179\u20131184. doi: 10.1002/ptr.4840.", "ArticleIdList": ["10.1002/ptr.4840", "23007945"]}, {"Citation": "Choi H.J., Park Y.R., Nepal M., Choi B.Y., Cho N.P., Choi S.H., Heo S.R., Kim H.S., Yang M.S., Soh Y. Inhibition of osteoclastogenic differentiation by ikarisoside A in RAW 264.7 cells via JNK and NF-\u03baB signaling pathways. Eur. J. Pharmacol. 2010;636:28\u201335. doi: 10.1016/j.ejphar.2010.03.023.", "ArticleIdList": ["10.1016/j.ejphar.2010.03.023", "20353769"]}, {"Citation": "Xu W., Zhang Y., Yang M., Shen Z., Zhang X., Zhang W., Li H. LC-MS/MS method for the simultaneous determination of icariin and its major metabolites in rat plasma. J. Pharm. Biomed. Anal. 2007;45:667\u2013672. doi: 10.1016/j.jpba.2007.07.007.", "ArticleIdList": ["10.1016/j.jpba.2007.07.007", "17706393"]}, {"Citation": "Zhao H., Fan M., Fan L., Sun J.G., Guo D. Liquid chormatography-tandem mass spectrometry analysis of metabolites in rats after administration of prenylflavonoids from Epimedium. J. Chromatogr. B. 2010;878:1113\u20131124. doi: 10.1016/j.jchromb.2010.03.023.", "ArticleIdList": ["10.1016/j.jchromb.2010.03.023", "20378425"]}, {"Citation": "Zhai Y.K., Ge B.F., Chen K.M., Ma H.P., Ming L.G., Li Z.F. Comparative study on the osteogenic differentiation of rat bone marrow stromal cells effected by icariin and icariside II. Zhongyaocai. 2010;33:1896\u20131900.", "ArticleIdList": ["21548368"]}, {"Citation": "Yao D., Xie X.H., Wang X.L., Wan C., Lee Y.W., Chen S.H., Pei D.Q., Wang Y.X., Li G., Qin L. Icaritin, an exogenous phytomolecule, enhances osteogenesis but not antiogenesis - an in vitro efficacy study. PLoS ONE. 2012;7:e41264.", "ArticleIdList": ["PMC3431393", "22952579"]}, {"Citation": "Sheng H., Rui X.F., Sheng C.J., Li W.J., Cheng X.Y., Jhummon N.P., Yu Y.C., Qu S., Zhang G., Qin L. A novel semisynthetic molecule icaritin stimulates osteogenic defferentiation and inhibits adipogenesis of mesenchymal stem cells. Int. J. Med. Sci. 2013;10:782\u2013789. doi: 10.7150/ijms.6084.", "ArticleIdList": ["10.7150/ijms.6084", "PMC3638303", "23630444"]}, {"Citation": "Peng S., Zhang G., Zhang B.T., Guo B., He Y., Bakker A.J., Pan X., Zhen W., Hung L., Qin L., et al. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats. Bone. 2013;55:230\u2013240. doi: 10.1016/j.bone.2013.02.012.", "ArticleIdList": ["10.1016/j.bone.2013.02.012", "23486180"]}, {"Citation": "Zhang G., Qin L., Shang H., Wang X.L., Wang Y.X., Yeung D.K., Griffith J.F., Yao X.S., Xie X.H., Li Z.R., et al. A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. Bone. 2009;44:345\u2013356. doi: 10.1016/j.bone.2008.10.035.", "ArticleIdList": ["10.1016/j.bone.2008.10.035", "PMC7185883", "19015051"]}, {"Citation": "Liu Y.Q., Yang Q.X., Cheng M.C., Xiao H.B. Synergistic inhibitory effect of icariside II with icaritin from Herba Epimedii on pre-osteoclastic RAW264.7 cell growth. Phytomedicine. 2014;21:1633\u20131637. doi: 10.1016/j.phymed.2014.07.016.", "ArticleIdList": ["10.1016/j.phymed.2014.07.016", "25442270"]}, {"Citation": "Xie X.H., Wang X.L., Zhang G., He Y.X., Wang X.H., Liu Z., He K., Peng J., Leng Y., Qin L. Structural and degradation characteristics of an innovative porous PLGA/TCP scaffold incorporated with bioactive molecular icaritin. Biomed. Mater. 2010;5:054109. doi: 10.1088/1748-6041/5/5/054109.", "ArticleIdList": ["10.1088/1748-6041/5/5/054109", "20876954"]}, {"Citation": "Chen S.H., Wang X.L., Xie X.H., Zheng L.Z., Yao D., Wang D.P., Leng Y., Zhang G., Qin L. Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: An in vitro efficacy study. Acta Biomater. 2012;8:3128\u20133137. doi: 10.1016/j.actbio.2012.04.030.", "ArticleIdList": ["10.1016/j.actbio.2012.04.030", "22543006"]}, {"Citation": "Xie X.H., Wang X.L., Zhang G., He Y.X., Leng Y., Tang T.T., Pan X., Qin L. Biofabrication of a PLGA-TCP-based porous bioactive bone substitute with sustained release of icaritin. J. Tissue Eng. Regen. Med. 2015;9:961\u2013972. doi: 10.1002/term.1679.", "ArticleIdList": ["10.1002/term.1679", "23255530"]}, {"Citation": "Chen S.H., Lei M., Xie X.H., Zhang L.Z., Yao D., Wang X.L., Li W., Zhao Z., Kong A., Xiao D.M., et al. PLGA/TCP composite scaffold incorporating bioactive phytomolecule icaritin for enhancement of bone defect repair in rabbits. Acta Biomater. 2013;9:6711\u20136722. doi: 10.1016/j.actbio.2013.01.024.", "ArticleIdList": ["10.1016/j.actbio.2013.01.024", "23376238"]}, {"Citation": "Wang X.L., Xie X.H., Zhang G., Chen S.H., Yao D., He K., Wang X.H., Yao X.S., Leng Y., Fung K.P., et al. Exogenous phytoestrogenic molecule icaritin incorporated into a porous scaffold for enhancing bone defect repair. J. Orthop. Res. 2013;31:164\u2013172. doi: 10.1002/jor.22188.", "ArticleIdList": ["10.1002/jor.22188", "22807243"]}, {"Citation": "Qin L., Yao D., Zheng L., Liu W.C., Liu Z., Lei M., Huang L., Xie X., Wang X., Chen Y., et al. Phytomolecule icaritin incorporated PLGA/TCP scaffold for steroid-associated osteonecrosis: Proof-of-concept for prevention of hip joint collapse in bipedal emus and mechanistic study in quadrupedal rabbits. Biomaterials. 2015;59:125\u2013143. doi: 10.1016/j.biomaterials.2015.04.038.", "ArticleIdList": ["10.1016/j.biomaterials.2015.04.038", "PMC7111223", "25968462"]}, {"Citation": "Zhang Y., Li X.L., Lai W.P., Chen B., Chow H.K., Wu C.F., Wang N.L., Yao X.S., Wong M.S. Anti-osteoporotic effect of Erythrina variegata L. in ovariectomized rats. J. Ethnopharmacol. 2007;109:165\u2013169. doi: 10.1016/j.jep.2006.07.005.", "ArticleIdList": ["10.1016/j.jep.2006.07.005", "16920298"]}, {"Citation": "Zhang Y., Li Q., Li X.L., Wan H.Y., Wong M.S. Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption. Br. J. Nutr. 2010;104:965\u2013971. doi: 10.1017/S0007114510001789.", "ArticleIdList": ["10.1017/S0007114510001789", "20487580"]}, {"Citation": "Zhang Y., Li X.L., Yao X.S., Wong M.S. Osteogenic activities of genistein derivatives were influenced by the presence of prenyl group at ring A. Arch. Pharm. Res. 2008;31:1534\u20131539. doi: 10.1007/s12272-001-2147-5.", "ArticleIdList": ["10.1007/s12272-001-2147-5", "19099220"]}, {"Citation": "Zhang R., Liu Z.G., Li C., Hu S.J., Liu L., Wang J.P., Mei Q.B. Du-zhong (Eucommia ulmoides Oliv.) cortex extract prevents OVX-induced osteoporosis in rats. Bone. 2009;45:553\u2013559. doi: 10.1016/j.bone.2008.08.127.", "ArticleIdList": ["10.1016/j.bone.2008.08.127", "18835589"]}, {"Citation": "Kim J.Y., Lee J.I., Song M., Lee D., Song J., Kim S.Y., Park J., Choi H.Y., Kim H. Effects of Eucommia ulmoides extract on longitudinal bone growth rate in adolescent female rats. Phytother. Res. 2015;29:148\u2013153. doi: 10.1002/ptr.5195.", "ArticleIdList": ["10.1002/ptr.5195", "25087723"]}, {"Citation": "Pan Y., Niu Y., Li C., Zhai Y., Zhang R., Guo X., Mei Q. Du-zhong (Eucommia ulmoides) prevents disuse-induced osteoporosis in hind limb suspension rats. Am. J. Chin. Med. 2014;42:143\u2013155. doi: 10.1142/S0192415X14500104.", "ArticleIdList": ["10.1142/S0192415X14500104", "24467541"]}, {"Citation": "Ha H., Ho J., Shin S., Kim H., Kook S., Kim I.H., Kim C. Effects of Eucommiae Cortex on osteoblast-like cell proliferation and osteoclast inhibition. Arch. Pharm. Res. 2003;26:929\u2013936. doi: 10.1007/BF02980202.", "ArticleIdList": ["10.1007/BF02980202", "14661859"]}, {"Citation": "Zhang R., Pan Y.L., Hu S.J., Kong X.H., Juan W., Mei Q.B. Effects of total lignans from Eucommia ulmoides barks prevent bone loss in vivo and in vitro. J. Ethnopharmacol. 2014;155:104\u2013112. doi: 10.1016/j.jep.2014.04.031.", "ArticleIdList": ["10.1016/j.jep.2014.04.031", "24786573"]}, {"Citation": "Tan X.L., Zhang Y.H., Cai J.P., Zhu L.H., Ge W.J., Zhang X. 5-(Hydroxymethyl)-2-furaldehyde inhibits adipogenic and enhances osteogenic differentiation of rat bone mesenchymal stem cells. Nat. Prod. Commun. 2014;9:529\u2013532.", "ArticleIdList": ["24868876"]}, {"Citation": "Lin J., Fan Y.J., Mehl C., Zhu J.J., Chen H., Jin L.Y., Xu J.H., Wang H.M. Eucommia ulmoides Oliv. antagonizes H2O2-induced rat osteoblastic MC3T3-E1 apoptosis by inhibiting expressions of capases 3, 6, 7 and 9. J. Zhejiang Univ. Sci. B. 2011;12:47\u201354. doi: 10.1631/jzus.B1000057.", "ArticleIdList": ["10.1631/jzus.B1000057", "PMC3017416", "21194186"]}, {"Citation": "Zhang W., Fujikawa T., Mizuno K., Ishida T., Ooi K., Hirata T., Wada A. Eucommia leaf extract (ELE) prevents OVX-induced osteoporosis and obesity in rats. Am. J. Chin. Med. 2012;40:735\u2013752. doi: 10.1142/S0192415X12500553.", "ArticleIdList": ["10.1142/S0192415X12500553", "22809028"]}, {"Citation": "Li Y., Wang M.J., Li S., Zhang Y.M., Zhao Y., Xie R.M., Sun W.J. Effect of total glycosides from Eucommia ulmoides seed on bone microarchitecture in rats. Phytother. Res. 2011;25:1895\u20131897. doi: 10.1002/ptr.3543.", "ArticleIdList": ["10.1002/ptr.3543", "21674630"]}, {"Citation": "Che C.T., Wong M.S. Ligustrum lucidum and its constituents: A mini-review on the anti-osteoporosis potential. Nat. Prod. Commun. 2015;10:2189\u20132194.", "ArticleIdList": ["26882695"]}, {"Citation": "Li J.X., Hareyama T., Tezuka Y., Zhang Y., Miyahara T., Kadota S. Five new oleanolic acid glycosides from Achyranthes bidentata with inhibitory activity on osteoclast formation. Plant Med. 2005;71:673\u2013679. doi: 10.1055/s-2005-871275.", "ArticleIdList": ["10.1055/s-2005-871275", "16041655"]}, {"Citation": "Zhang Y., Li J.X., Zhao J., Wang S.Z., Pan Y., Tanaka K., Kadota S. Synthesis and activity of oleanolic acid derivatives, a novel class of inhibitors of osteoclast formation. Bioorg. Med. Chem. Lett. 2005;15:1629\u20131632. doi: 10.1016/j.bmcl.2005.01.061.", "ArticleIdList": ["10.1016/j.bmcl.2005.01.061", "15745811"]}, {"Citation": "Li J.F., Zhao Y.J., Cai M.M., Li X.F., Li J.X. Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity. Eur. J. Med. Chem. 2009;44:2796\u20132806. doi: 10.1016/j.ejmech.2008.12.024.", "ArticleIdList": ["10.1016/j.ejmech.2008.12.024", "19171409"]}, {"Citation": "Li J.F., Chen S.J., Zhao Y., Li J.X. Glycoside modification of oleanolic acid derivatives as a novel class of anti-osteoclast formation agents. Carbohydr. Res. 2009;344:599\u2013605. doi: 10.1016/j.carres.2009.01.019.", "ArticleIdList": ["10.1016/j.carres.2009.01.019", "19217081"]}, {"Citation": "Bian Q., Liu S.F., Huang J.H., Yang Z., Tang D.Z., Zhou Q., Ning Y., Zhao Y.J., Lu S., Shen Z.Y. Oleanolic acid exerts an osteoprotective effect in ovariectomy-induced osteoporotic rats and stimulates the osteoblasic differentiation of bone mesenchymal stem cells in vitro. Menopause. 2012;19:225\u2013233. doi: 10.1097/gme.0b013e3182272ef1.", "ArticleIdList": ["10.1097/gme.0b013e3182272ef1", "22011754"]}, {"Citation": "Kim J.Y., Cheon Y.H., Oh H.M., Rho M.C., Erkhembaatar M., Kim M.S., Lee C.H., Kim J.J., Choi M.K., Yoon K.H., et al. Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLC\u03b32-Ca(2+)-NFATC1 signaling and suppresses bone loss in mice. Bone. 2014;60:104\u2013111. doi: 10.1016/j.bone.2013.12.013.", "ArticleIdList": ["10.1016/j.bone.2013.12.013", "24361669"]}, {"Citation": "Lee S.U., Park S.J., Kwak H.B., Oh J., Min Y.K., Kim S.H. Anabolic activity of ursolic acid in bone: Stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo. Pharmacol. Res. 2008;58:290\u2013296. doi: 10.1016/j.phrs.2008.08.008.", "ArticleIdList": ["10.1016/j.phrs.2008.08.008", "18822379"]}, {"Citation": "Tan H., Furuta S., Nagata T., Ohnuki K., Akasaka a., Shirouchi B., Sato M., Kondo R., Shimizu K. Inhibitory effects of the leaves of ioquat (Eriobotrya japonica) on bone mineral density loss in ovariectomized mice and osteoclast differentiation. J. Agric. Food Chem. 2014;62:836\u2013841. doi: 10.1021/jf402735u.", "ArticleIdList": ["10.1021/jf402735u", "24404864"]}, {"Citation": "Tan H., Ashour A., Katakura Y., Shimizu K. A structure-activity relationship study on anti-osteoclastogenesis effect of triterpenoids from the leaves of ioquat (Eriobotrya japonica) Phytomedicine. 2015;22:498\u2013503. doi: 10.1016/j.phymed.2015.03.002.", "ArticleIdList": ["10.1016/j.phymed.2015.03.002", "25925972"]}, {"Citation": "Jiang C., Xiao F., Gu X., Zhai Z., Liu X., Wang W., Tang T., Wang Y., Zhu Z., Dai K., et al. Inhibitory effects of ursolic acid on osteoclastogenesis and titanium particle-induced osteolysis are mediated primarily via suppression of NF-\u03baB signaling. Biochimie. 2015;111:107\u2013118. doi: 10.1016/j.biochi.2015.02.002.", "ArticleIdList": ["10.1016/j.biochi.2015.02.002", "25681755"]}, {"Citation": "Chen Q., Yang L., Zhang G., Wang F. Bioactivity-guided isolation of antiosteoporotic compounds from Ligustrum lucidum. Phytother. Res. 2013;27:973\u2013979. doi: 10.1002/ptr.4820.", "ArticleIdList": ["10.1002/ptr.4820", "22893624"]}, {"Citation": "Huang Y., Wu Y., Wu J., Yi J., Zhang Q., Chen T., Wu J. Chemical constituents from Ligustrum lucidum differentially promote bone formation and prevent oxidative damage in osteoblastic UMR-106 cells. Lat. Am. J. Pharmacy. 2014;33:258\u2013265."}, {"Citation": "Garcia-Martinez O., Rivas A., Ramos-Torrecillas J., de Luna-Bertos E., Ruiz C. The effect of olive oil on osteoporosis prevention. Int. J. Food Sci. Nutr. 2014;65:834\u2013840. doi: 10.3109/09637486.2014.931361.", "ArticleIdList": ["10.3109/09637486.2014.931361", "24975408"]}, {"Citation": "Zhang S.C., Wang S.Q., Zhao S. The effect of salidroside on leptin expression of diabetic rats with osteoporosis. Chin. J. Pathophysiol. 2009;25:787\u2013788."}, {"Citation": "Seo B.I., Ku S.K., Cha E.M., Park J.H., Kim J.D., Choi H.Y., Lee H.S. Effect of Morindae Radix extracts on experimental osteoporosis in sciatic neurectomized mice. Phytother. Res. 2005;19:231\u2013238. doi: 10.1002/ptr.1683.", "ArticleIdList": ["10.1002/ptr.1683", "15934024"]}, {"Citation": "Zhu M.Y., Wang C.J., Zhang H.S., Pei X.W., Fen J.M. Protective effect of polysaccharides from Morinda officinalis on bone loss in ovariectomzied rats. Int. J. Biol. Macromol. 2008;43:276\u2013278.", "ArticleIdList": ["18638500"]}, {"Citation": "Li N., Qin L.P., Han T., QWu Y.B., Zhang Q.Y., Zhang H. Inhibitory effects of Morinda officinalis extract on bone loss in ovariectomized rats. Molecules. 2009;14:2049\u20132061. doi: 10.3390/molecules14062049.", "ArticleIdList": ["10.3390/molecules14062049", "PMC6254270", "19513005"]}, {"Citation": "Wu Y.B., Zheng C.J., Qin L.P., Sun L.N., Han T., Jiao L., Zhang Q.Y., Wu J.Z. Antiosteoporotic activity of anthraquinones from Morinda officinalis on osteoblasts and osteoclasts. Molecules. 2009;14:573\u2013583. doi: 10.3390/molecules14010573.", "ArticleIdList": ["10.3390/molecules14010573", "PMC6253840", "19169204"]}, {"Citation": "Bao L., Qin L., Liu L., Wu Y., Han T., Xue L., Zhang Q. Anthraquinone compounds from Morinda officinalis inhibit osteoclastic bone resoprtion in vitro. Chem. Biol. Interations. 2011;194:97\u2013105. doi: 10.1016/j.cbi.2011.08.013.", "ArticleIdList": ["10.1016/j.cbi.2011.08.013", "21945525"]}, {"Citation": "Ma X., Liang J., Zheng C., Hu C., Zhao X., Rahman K., Qin L. Phenylpropanoids from Podocarpium podocarpum. Pharm. Biol. 2013;51:1021\u20131025. doi: 10.3109/13880209.2013.774425.", "ArticleIdList": ["10.3109/13880209.2013.774425", "23738775"]}, {"Citation": "Ma X.Q., Zheng C.J., Zhang Y., Hu C.L., Lin B., Fu X.Y., Han L.Y., Xu L.S., Rahman K., Qin L.P. Antiosteoporotic flavonoids from Podcarpium podocarpum. Phytochem. Lett. 2013;6:118\u2013122. doi: 10.1016/j.phytol.2012.12.004.", "ArticleIdList": ["10.1016/j.phytol.2012.12.004"]}, {"Citation": "Ye Q., Ma X.Q., Hu C.L., Lin B., Xu L.S., Zheng C.J., Qin L.P. Antiosteoporotic activity and consituents of Podocarpium podocarpum. Phytomedicine. 2015;22:94\u2013102. doi: 10.1016/j.phymed.2014.11.004.", "ArticleIdList": ["10.1016/j.phymed.2014.11.004", "25636877"]}, {"Citation": "Bhargavan B., Gautam A.K., Singh D., Kumar A., Chaurasia S., Tyagi A.M., Yadav D.K., Mishra J.S., Singh A.B., Sanyal S., et al. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling. J. Cell. Biochem. 2009;108:388\u2013399. doi: 10.1002/jcb.22264.", "ArticleIdList": ["10.1002/jcb.22264", "19598169"]}, {"Citation": "Tsai M.H., Huang G.S., Hung Y.C., Bin L., Liao L.T., Lin L.W. Psoralea corylifolia extract ameliorates experimental osteoporosis in ovariectomized rats. Am. J. Chin. Med. 2007;35:669\u2013680. doi: 10.1142/S0192415X07005168.", "ArticleIdList": ["10.1142/S0192415X07005168", "17708633"]}, {"Citation": "Wong R.W., Rabie A.B. Systemic effect of Fructus Psoraleae extract on bone in mice. Phytother. Res. 2010;24:1578\u20131580. doi: 10.1002/ptr.3184.", "ArticleIdList": ["10.1002/ptr.3184", "20564544"]}, {"Citation": "Khushboo P.S., Jadhav V.M., Kadam V.J., Sathe N.S. Psoralea corylifolia Linn.\u2014\u201cKushtanashini\u201d. Phyarmacogn. Rev. 2010;4:69\u201376. doi: 10.4103/0973-7847.65331.", "ArticleIdList": ["10.4103/0973-7847.65331", "PMC3249905", "22228944"]}, {"Citation": "Chopra B., Dhingra A.K., Dhar K.L. Psoralea corylifolia L. (Buguchi)\u2014folklore to modern evidence: Review. Fitoterapia. 2013;90:44\u201356. doi: 10.1016/j.fitote.2013.06.016.", "ArticleIdList": ["10.1016/j.fitote.2013.06.016", "23831482"]}, {"Citation": "Xin D., Wang H., Yang J., Su Y.F., Fan G.W., Wang Y.F., Zhu Y., Gao X.M. Phytoestrogens from Psoralea corylifolia reveal estrogen receptor-subtype selectivity. Phytomedicine. 2010;17:126\u2013131. doi: 10.1016/j.phymed.2009.05.015.", "ArticleIdList": ["10.1016/j.phymed.2009.05.015", "19577453"]}, {"Citation": "Wong R.W., Rabie A.B. Effect of psoralen on bone formation. J. Orthop. Res. 2011;29:158\u2013164. doi: 10.1002/jor.21124.", "ArticleIdList": ["10.1002/jor.21124", "20196083"]}, {"Citation": "Wong R.W., Rabie A.B. Effect of Buguzhi (Psoralea corylifolia fruit) extract on bone formation. Phytother. Res. 2010;24(Suppl. 2):S155\u2013S160. doi: 10.1002/ptr.3049.", "ArticleIdList": ["10.1002/ptr.3049", "19953524"]}, {"Citation": "Yang Z., Huang J.H., Liu S.F., Zhao Y.J., Shen Z.Y., Wang Y.J., Bian Q. The osteoprotective effect of psoralen in ovariectomy-induced osteoporotic rats via stimulaitng the osteoblastic differentiation from bone messenchymal stem cells. Menopause. 2012;19:1156\u20131164. doi: 10.1097/gme.0b013e3182507e18.", "ArticleIdList": ["10.1097/gme.0b013e3182507e18", "22781784"]}, {"Citation": "Tang D.Z., Yang F., Yang Z., Huang J., Shi Q., Chen D., Wang Y.J. Psoralen stimulates osteoblast differentiation through activation of BMP signaling. Biochem. Biophys. Res. Commun. 2011;405:256\u2013261. doi: 10.1016/j.bbrc.2011.01.021.", "ArticleIdList": ["10.1016/j.bbrc.2011.01.021", "PMC3060402", "21219873"]}, {"Citation": "Xu K., Pan X., Sun Y., Xu W., Njunge L., Yang L. Psoralen activates cartilaginous cellular functions of rat chondrocytes in vitro. Pharm. Biol. 2015;53:1010\u20131015. doi: 10.3109/13880209.2014.952835.", "ArticleIdList": ["10.3109/13880209.2014.952835", "25471084"]}, {"Citation": "Yang L., Sun X., Geng X. Effects of psoralen on chondrocyte degeneration in lumbar intervertebral disc of rats. Pak. J. Pharm. Sci. 2015;28(Suppl. 2):667\u2013670.", "ArticleIdList": ["25796142"]}, {"Citation": "Ming L., Ge B., Chen K., Ma H., Zhai Y. Effects of isopsoralen on bone marrow stromal stem cells differentiation and proliferation in vitro. China J. Chin. Med. (Zhongguo Zhongyao Zazhi) 2011;36:2124\u20132128.", "ArticleIdList": ["22066454"]}, {"Citation": "Ming L.G., Cheng K.M., Ge B.F., Ma H.P., Zai Y.K. Effect of isopsoralen on the proliferation and differentiation of osteoblasts in vitro. Chin. Med. Mater. (Zhongyaocai) 2011;34:404\u2013408.", "ArticleIdList": ["21823459"]}, {"Citation": "Li J.P., Wang X.J., Zeng Y., Lin Q., Mo X.M., Liu S.J., Yang J. Study on the effect of psoralidin on anti-experimental postmenopausal osteoporosis and its mechanism. China J. Chin. Med. (Zhongguo Zhongyao Zazhi) 2013;38:1816\u20131819.", "ArticleIdList": ["24010302"]}, {"Citation": "Wang D., Li F., Jiang Z. Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids. Planta Med. 2001;67:748\u2013749. doi: 10.1055/s-2001-18343.", "ArticleIdList": ["10.1055/s-2001-18343", "11731919"]}, {"Citation": "Xiong Z., Wang D., Xu Y., Li F. Osteoblastic differentiation bioassay and its application to investigating the activity of fractions and compounds from Psoralea corylifolia L. Pharmazie. 2003;58:925\u2013928.", "ArticleIdList": ["14703975"]}, {"Citation": "Li W.D., Yan C.P., Wu Y., Weng Z.B., Yin F.Z., Yang G.M., Cai B.C., Chen Z.P. Osteoblasts proliferation and differentiation stimulting activities of the main components of Fructus Psoraleae corylifoliae. Phytomedicine. 2014;21:400\u2013405. doi: 10.1016/j.phymed.2013.09.015.", "ArticleIdList": ["10.1016/j.phymed.2013.09.015", "24220018"]}, {"Citation": "Don M.J., Lin L.C., Chiou W.F. Neobavaisoflavone stimulates osteogenesis via p38-mediated up-regulation of transcription factors and osteoid genes expression in MC3T3-E1 cells. Phytomedicine. 2012;19:551\u2013561. doi: 10.1016/j.phymed.2012.01.006.", "ArticleIdList": ["10.1016/j.phymed.2012.01.006", "22397994"]}, {"Citation": "Lim S.H., Ha T.Y., Kim S.R., Ahn J., Park H.J., Kim S. Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomized Sprague-Dawley rats. Br. J. Nutr. 2009;101:1031\u20131039. doi: 10.1017/S0007114508066750.", "ArticleIdList": ["10.1017/S0007114508066750", "18801207"]}, {"Citation": "Park C.K., Lee Y.C., Chang E.J., Lee M.H., Yoon J.H., Ryu J.H., Kim H.H. Bavachalcone inhibits osteoclast differentiation through suppression of NFATc1 induction by RANKL. Biochem. Pharmacol. 2008;75:2175\u20132182. doi: 10.1016/j.bcp.2008.03.007.", "ArticleIdList": ["10.1016/j.bcp.2008.03.007", "18433733"]}, {"Citation": "Zhou Y.X., Zhang H., Peng C. Puerarin: A review of pharmacological effects. Phytother. Res. 2014;28:961\u2013975. doi: 10.1002/ptr.5083.", "ArticleIdList": ["10.1002/ptr.5083", "24339367"]}, {"Citation": "Wei S.Y., Chen Y., Xu X.Y. Progress on the pharmacological research of puerarin: A review. Chin. J. Nat. Med. 2014;12:407\u2013414. doi: 10.1016/S1875-5364(14)60064-9.", "ArticleIdList": ["10.1016/S1875-5364(14)60064-9", "24969520"]}, {"Citation": "Wang X., Wu J., Chiba H., Umegaki K., Yamada K., Ishimi Y. Puerariae Radix prevents bone loss in ovariectomized mice. J. Bone Miner. Metab. 2003;21:268\u2013275. doi: 10.1007/s00774-003-0420-z.", "ArticleIdList": ["10.1007/s00774-003-0420-z", "12928827"]}, {"Citation": "Huang H., Jin B.Q., Sun G.J., Du X.F., Wan X.C. Effects of puerarin on bone metabolism in ovariectomized rats. Chin. J. Geratol. (Zhongguo Laonianxue Zazhi) 2009;29:2482\u20132484."}, {"Citation": "Wang P.P., Zhu X.F., Yang L., Liang H., Feng S.W., Zhang R.H. Puerarin stimulates osteoblasts differentiation and bone formation through estrogen receptor, p38 MAPK, and Wnt/\u03b2-catenin pathways. J. Asian Nat. Prod. Res. 2012;14:897\u2013905. doi: 10.1080/10286020.2012.702757.", "ArticleIdList": ["10.1080/10286020.2012.702757", "22917468"]}, {"Citation": "Liu H., Li B.B. Effect of puerarin on osteoporosis resulted from ovariectomy in rats. Chin. J. Comp. Med. (Zhongguo Bijiao Yixue Zazhi) 2012;22:16\u201320."}, {"Citation": "Li B., Liu H., Jia S. Puerarin enhances bone mass by promoting osteoblastogenesis and slightly lowering bone marrow adiposity in ovariectomized rats. Biol. Pharm. Bull. 2014;37:1919\u20131925. doi: 10.1248/bpb.b14-00513.", "ArticleIdList": ["10.1248/bpb.b14-00513", "25590084"]}, {"Citation": "Wong R.W., Rabie B. Effect of puerarin on bone formation. Osteoarthr. Cartil. 2007;15:894\u2013899. doi: 10.1016/j.joca.2007.02.009.", "ArticleIdList": ["10.1016/j.joca.2007.02.009", "17379543"]}, {"Citation": "Zhang M.Y., Qiang H., Yang H.Q., Dang X.Q., Wang K.Z. In vitro and in vivo effects of puerarin on promotion of osteoblast bone formation. Chin. J. Integr. Med. 2012;18:276\u2013282. doi: 10.1007/s11655-012-1056-4.", "ArticleIdList": ["10.1007/s11655-012-1056-4", "22457138"]}, {"Citation": "Liang J., Chen H., Pan W., Xu C. Puerarin inhibits caspase-3 expression in osteoblasts of diabetic rats. Mol. Med. Rep. 2012;5:1419\u20131422.", "ArticleIdList": ["22470138"]}, {"Citation": "Wang Y., Yin L., Li Y., Liu P., Cui Q. Preventive effects of puerarin on alcohol-induced osteonecrosis. Clin. Orthop. Relat. Res. 2008;466:1059\u20131067. doi: 10.1007/s11999-008-0178-7.", "ArticleIdList": ["10.1007/s11999-008-0178-7", "PMC2311465", "18350350"]}, {"Citation": "Michihara S., Tanaka T., Uzawa Y., Moriyama T., Kawamura Y. Puerarin exerted anti-osteoporotic action independent of estrogen receptor-mediated pathway. J. Nutr. Sci. Vitaminol. 2012;58:202\u2013209. doi: 10.3177/jnsv.58.202.", "ArticleIdList": ["10.3177/jnsv.58.202", "22878391"]}, {"Citation": "Liu H., Li B.B. Inhibitory effect of puerarin on osteoclastic bone resorption induced by 1,25-dihydroxyvitamin D3 in vitro: The optimal concentration of puerarin. Chin. Res. Tissue Eng. (Zhongguo Zuzhi Gongcheng Yanjiu) 2012;28:5141\u20135144."}, {"Citation": "Zhang Y., Zeng X., Zhang L., Zheng X. Stimulatory effect of puerarin on bone formation through activation of PI3K/AKT pathway in rat calvaria osteoblasts. Planta Med. 2007;73:341\u2013347. doi: 10.1055/s-2007-967168.", "ArticleIdList": ["10.1055/s-2007-967168", "17443435"]}, {"Citation": "Wang C., Meng M.X., Tang X.L., Chen K.M., Zhang L., Liu W.N., Zhao Y.Y. The proliferation, differentiation, and mineralization effects of puerarin on osteoblasts in vitro. Chin. J. Nat. Med. 2014;12:436\u2013442. doi: 10.1016/S1875-5364(14)60068-6.", "ArticleIdList": ["10.1016/S1875-5364(14)60068-6", "24969524"]}, {"Citation": "Wang Y., Wang W.L., Xie W.L., Li L.Z., Sun J., Sun W.J., Gong H.Y. Puerarin stimulates proliferation and differentiation and protects against cell dealth in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/AKT activation. Phytomedicine. 2013;20:787\u2013796. doi: 10.1016/j.phymed.2013.03.005.", "ArticleIdList": ["10.1016/j.phymed.2013.03.005", "23639192"]}, {"Citation": "Liu L.J., Liu L.Q., Bo T., Li S.J., Zhu Z., Cui R.R., Mao D.A. Puerarin suppresses apoptosis of human osteoblasts via ERK signaling pathway. Int. J. Endocrinol. 2013:786574. doi: 10.1155/2013/786574.", "ArticleIdList": ["10.1155/2013/786574", "PMC3694486", "23843790"]}, {"Citation": "Sheu S.Y., Tsai C.C., Sun J.S., Chen M.H., Liu M.H., Sun M.G. Stimulatory effect of puerarin on bone formation through co-activation of nitric oxide and bone morphogenetic protein-2/mitogen-activated protein kinases pathways in mice. Chin. Med. J. (Engl. Ed.) 2012;125:3646\u20133653.", "ArticleIdList": ["23075718"]}, {"Citation": "Wang Y., Yang C., Xie W.L., Zhao Y.W., Li Z.M., Sun W.J., Li L.Z. Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-\u03baB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. Phytomedicine. 2014;21:1032\u20131036. doi: 10.1016/j.phymed.2014.04.012.", "ArticleIdList": ["10.1016/j.phymed.2014.04.012", "24854571"]}, {"Citation": "Lv H., Che T., Tang X.L., Liu L., Cheng J. Puerarin enhances proliferation and osteoblastic differentiation of human bone marrow stromal cells via a nitric oxide/cyclic guanosine monophosphate signaling pathway. Mol. Med. Rep. 2015;12:2283\u20132290. doi: 10.3892/mmr.2015.3647.", "ArticleIdList": ["10.3892/mmr.2015.3647", "25892538"]}, {"Citation": "Zhan X.Q., Qian K.Q., Sun Y.M. Effect of puerarin on TGF-\u03b21/SMAD pathway in MC3T3-E1 cells. Chin. Patent Drugs (Zhongchenyao) 2013;35:1121\u20131124."}, {"Citation": "Tiyasatkulkovit W., Charoenphandhu N., Wongdee K., Thongbunchoo J., Krishnamra N., Malaivijitnond S. Upregulation of osteoblastic differentiation marker mRNA expression in osteoblast-like UMR 106 cells by puerarin and phytoestrogens from Pueraria mirifica. Phytomedicine. 2012;19:1147\u20131155. doi: 10.1016/j.phymed.2012.07.010.", "ArticleIdList": ["10.1016/j.phymed.2012.07.010", "22951392"]}, {"Citation": "Tiyasatkulkovit W., Malaivijitnond S., Charoenphandhu N., Havill L.M., Ford A.L., VandeBerg J.L. Pueraria mirifica extract and puerarin enhance proliferation and expression of alkaline phosphatase and type 1 collagen in primary baboon osteoblasts. Phytomedicine. 2014;21:1498\u20131503. doi: 10.1016/j.phymed.2014.06.019.", "ArticleIdList": ["10.1016/j.phymed.2014.06.019", "PMC4679364", "25442257"]}, {"Citation": "Yang X., Zhang H., Wang J., Zhang Z., Li C. Puerarin decreases bone loss and collagen destruction in rats with ligature-induced periodontitis. J. Periodontal Res. 2015;50:748\u2013757. doi: 10.1111/jre.12261.", "ArticleIdList": ["10.1111/jre.12261", "25645818"]}, {"Citation": "Li H., Chen B., Pang G., Chen J., Xie J., Huang H. Anti-osteoporotic activity of puerarin 6\u2032\u2032-O-xyloside on ovariectomized mice and its potential mechanisms. Pharm. Biol. 2016;54:111\u2013117. doi: 10.3109/13880209.2015.1017885.", "ArticleIdList": ["10.3109/13880209.2015.1017885", "25857587"]}, {"Citation": "Oh K.O., Kim S.W., Kim J.Y., Ko S.Y., Kim H.M., Baek J.H., Ryoo H.M., Kim J.K. Effect of Rehmannia glutinosa Libosch extracts on bone metabolism. Clin. Chim. Acta. 2003;334:185\u2013195. doi: 10.1016/S0009-8981(03)00238-9.", "ArticleIdList": ["10.1016/S0009-8981(03)00238-9", "12867291"]}, {"Citation": "Lim D.W., Kim Y.T. Dried root of Rehmannia glutinosa prevents bone loss in ovariectomized rats. Molecules. 2013;18:5804\u20135813. doi: 10.3390/molecules18055804.", "ArticleIdList": ["10.3390/molecules18055804", "PMC6270096", "23685937"]}, {"Citation": "Lee S.Y., Lee K.S., Yi S.H., Kook S.H., Lee J.C. Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-\u03baB pathway and attenuating ROS production. PLoS ONE. 2013;8:e80873. doi: 10.1371/journal.pone.0080873.", "ArticleIdList": ["10.1371/journal.pone.0080873", "PMC3851776", "24324641"]}, {"Citation": "Kiem P.V., Quang T.H., Huong T.T., Nhung L.T.H., Nguyen X.C., Minh C.V., Choi E.M., Kim Y.H. Chemical constituents of Acanthus ilicifolius L. And effect on osteoblastic MC3T3-E1 cells. Arch. Pharm. Res. 2008;31:823\u2013829. doi: 10.1007/s12272-001-1232-3.", "ArticleIdList": ["10.1007/s12272-001-1232-3", "18704321"]}, {"Citation": "Kim K.A., Lee S.A., Kim K.H., Lee K.S., Lee J.C. Acteoside inhibits irradiation-mediated decreases in the viability and DNA synthesis of MC3T3-E1 cells. Food Sci. Biotech. 2013;22:845\u2013851. doi: 10.1007/s10068-013-0154-1.", "ArticleIdList": ["10.1007/s10068-013-0154-1"]}, {"Citation": "Chae H.J., Chae S.W., Yun D.H., Keum K.S., Yoo S.K., Kim H.R. Prevention of bone loss in ovariectomized rats: The effect of Salvia miltiorrhiza extracts. Immunopharmacol. Immunotoxicol. 2004;26:135\u2013144. doi: 10.1081/IPH-120029951.", "ArticleIdList": ["10.1081/IPH-120029951", "15106738"]}, {"Citation": "Cui L., Zou L.Y., Liu Y.Y., Ai C.M., Wu T., Wang Y. Preventing cancellous bone loss in steroid-treated rats and stimulating bone formation by water extract of Salvia miltiorrhiza and danshensu. Chin. Pharmacol. Bull. 2004;20:286\u2013291."}, {"Citation": "Miao B., Wang J., Zhu Y., Yue C., Chen M. Experimental study on the effect of Salvia miltiorrhiza on alveolar bone metabolism and variation in bone mass in diabetic rats. Zhongguo Zhongyao Zazhi. 2012;37:1659\u20131662.", "ArticleIdList": ["22994003"]}, {"Citation": "Wong R.W., Rabie A.B. Effect of danshen extract on bone formation. Ann. R. Aust. Coll. Dent. Surg. 2008;19:171\u2013174.", "ArticleIdList": ["22073474"]}, {"Citation": "Wu Y.B., Ni Z.Y., Shi Q.W., Dong M., Kiyota H., Gu Y.C., Cong B. Constituents from Salvia species and their biological activities. Chem. Rev. 2012;112:5967\u20136026. doi: 10.1021/cr200058f.", "ArticleIdList": ["10.1021/cr200058f", "22967178"]}, {"Citation": "Cui L., Liu Y.Y., Wu T., Ai C.M., Chen H.Q. Osteogenic effects of d-\u03b2-3,4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats. Acta Pharmacol. Sin. 2009;30:321\u2013332. doi: 10.1038/aps.2009.9.", "ArticleIdList": ["10.1038/aps.2009.9", "PMC4002398", "19262556"]}, {"Citation": "Cui L., Li T., Liu Y., Zhou L., Li P., Xu B., Huang L., Chen Y., Liu Y., Tian X., et al. Salvianolic acid B prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesis. PLoS ONE. 2012;7:e34647. doi: 10.1371/journal.pone.0034647.", "ArticleIdList": ["10.1371/journal.pone.0034647", "PMC3321026", "22493705"]}, {"Citation": "Cui L., Wu T., Liu Y.Y., Deng Y.F., Al C.M., Chen H.Q. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats. Acta Pharmacol. Sin. (Yaoli Xuebao) 2004;25:678\u2013684.", "ArticleIdList": ["15132837"]}, {"Citation": "Lee S.Y., Choi D.Y., Woo E.R. Inhibition of osteoclast differentiation by tanshinones from the root of Salvia miltiorrihiza Bunge. Arch. Pharm. Res. 2005;28:909\u2013913. doi: 10.1007/BF02973876.", "ArticleIdList": ["10.1007/BF02973876", "16178416"]}, {"Citation": "Kim H.K., Woo E.R., Lee H.W., Park H.R., Kim H.N., Jung Y.K., Choi J.Y., Chae S.W., Kim H.R., Chae H.J. The correlation of Salvia miltiorrhiza extract-induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIa, cryptotanshinone, and dihydrotanshinone. Immunopharmacol. Immunotoxicol. 2008;30:347\u2013364. doi: 10.1080/08923970801949133.", "ArticleIdList": ["10.1080/08923970801949133", "18569089"]}, {"Citation": "Kim H.H., Kim J.H., Kwak H.B., Huang H., Han S.H., Ha H., Lee S.W., Woo E.R., Lee Z.H. Inihbition of osteoclast differentiation and bone resorption by tanshinone IIa isolated from Salvia miltiorrhiza Bunge. Biochem. Pharmacol. 2004;67:1647\u20131656. doi: 10.1016/j.bcp.2003.12.031.", "ArticleIdList": ["10.1016/j.bcp.2003.12.031", "15081864"]}, {"Citation": "Kwak H.B., Yang D., Ha H., Lee J.H., Kim H.N., Woo E.R., Lee S., Kim H.H., Lee Z.H. Tanshinone IIa inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1. Exp. Mol. Med. 2006;38:256\u2013264. doi: 10.1038/emm.2006.31.", "ArticleIdList": ["10.1038/emm.2006.31", "16819284"]}, {"Citation": "Kwak H.B., Sun H.M., Ha H., Kim H.N., Lee J.H., Kim H.H., Shin H.I., Lee Z.H. Tanshinone IIa suppresses inflammatory bone loss by inhibiting the sysnthesis of prostaglandin E2 in osteoblasts. Eur. J. Pharmacol. 2008;601:30\u201337. doi: 10.1016/j.ejphar.2008.10.034.", "ArticleIdList": ["10.1016/j.ejphar.2008.10.034", "18973753"]}, {"Citation": "Nicolin V., Dal-Piaz F., Nori S.L., Narducci P., De Tommasi N. Inhibition of bone resorption by tanshinone VI isolated from Salvia miltiorrhiza Bunge. Eur. J. Histochem. 2010;54:e21. doi: 10.4081/ejh.2010.e21.", "ArticleIdList": ["10.4081/ejh.2010.e21", "PMC3167308", "20558342"]}, {"Citation": "Shama V., Panwar P., O\u2019Donoghue A.J., Cui H., Guido R.V., Craik C.S., Bromme D. Structural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor. Biochem. J. 2015;465:163\u2013173. doi: 10.1042/BJ20140809.", "ArticleIdList": ["10.1042/BJ20140809", "25279554"]}, {"Citation": "Chin A., Yang Y., Chai L., Wong R.W., Rabie A.B. Effects of medicinal herb Salvia miltiorrhiza on osteoblastic cells in vitro. J. Orthop. Res. 2011;29:1059\u20131063. doi: 10.1002/jor.21376.", "ArticleIdList": ["10.1002/jor.21376", "21319217"]}, {"Citation": "Xu D., Xu L., Zhou C., Lee W.Y., Wu T., Cui L., Li G. Salvianolic acid B promotes osteogenesis of human mesenchymal stem cells through activating ERK signaling pathway. Int. J. Biochem. Cell Biol. 2014;51:1\u20139. doi: 10.1016/j.biocel.2014.03.005.", "ArticleIdList": ["10.1016/j.biocel.2014.03.005", "24657587"]}, {"Citation": "Xie F., Wu C.F., Zhang Y., Yao X.S., Cheung P.Y., Chan A.S., Wong M.S. Increase in bone mass and bone strength by Sambucus williamsii Hance in ovariectomized rats. Biol. Pharm. Bull. 2005;28:1879\u20131885. doi: 10.1248/bpb.28.1879.", "ArticleIdList": ["10.1248/bpb.28.1879", "16204939"]}, {"Citation": "Zhang Y., Li Q., Wan H.Y., Xiao H.H., Lai W.P., Yao X.S., Wong M.S. Study of the mechanisms by which Sambucus williamsii Hance extract exert protective effects against ovariectomy-induced osteoporosis in vivo. Osteoporos. Int. 2011;22:703\u2013709. doi: 10.1007/s00198-010-1240-3.", "ArticleIdList": ["10.1007/s00198-010-1240-3", "20414641"]}, {"Citation": "Xiao H.H., Dai Y., Wan H.Y., Wong M.S., Yao X.S. Bone-protective effects of bioactive fractions and ingredients in Sambucus williamsii Hance. Br. J. Nutr. 2011;106:1802\u20131809. doi: 10.1017/S0007114511002546.", "ArticleIdList": ["10.1017/S0007114511002546", "21736773"]}, {"Citation": "Huang W.X., Yao X.S., Xiao H.H., Dai Y. Extraction method of active fraction from Chinese medicine Sambucus and its application for reducing risk of menopausal bone-related diseases. CN101773490. Chin. Patent. 2010 Jul 14;"}, {"Citation": "Xiao H.H., Dai Y., Wong M.S., Yao X.S. New lignans from the bioactive fraction of Sambucus williamsii Hance and proliferation actvities on osteoblast-like UMR 106 cells. Fitoterapia. 2014;94:29\u201335. doi: 10.1016/j.fitote.2014.01.012.", "ArticleIdList": ["10.1016/j.fitote.2014.01.012", "24462959"]}, {"Citation": "Xiao H.H., Gao Q.G., Ho M.X., Zhang Y., Wong K.C., Dai Y., Yao X.S., Wong M.S. An 8-O-4\u2032 norlignan exerts oestrogen-like actions in osteoblastic cells via rapid nongenomic ER signaling pathway. J. Ethnopharmacol. 2015;170:39\u201349. doi: 10.1016/j.jep.2015.05.012.", "ArticleIdList": ["10.1016/j.jep.2015.05.012", "25978953"]}, {"Citation": "Xiao H.H., Gao Q.G., Zhang Y., Wong K.C., Dai Y., Yao X.S., Wong M.S. Vanillic acid exerts oestrogen-like activities in osteoblast-like UMR 106 cells through MAP kinase (MEK/ERK)-mediated ER signaling pathway. J. Steroid Biochem. Mol. Biol. 2014;144(Part B):382\u2013391. doi: 10.1016/j.jsbmb.2014.08.002.", "ArticleIdList": ["10.1016/j.jsbmb.2014.08.002", "25106917"]}, {"Citation": "Joo S.S., Won T.J., Kang H.C., Lee D.I. Isoflavones extracted from Sophorae fructus upregulate IGF-1 and TGF-\u03b2 and inihbit osteoclastogenesis in rat bone marrow cells. Arch. Pharm. Res. 2004;27:99\u2013105. doi: 10.1007/BF02980054.", "ArticleIdList": ["10.1007/BF02980054", "14969347"]}, {"Citation": "Wang Z.L., Sun J.Y., Wang D.N., Xie Y.H., Wang S.W., Zhao W.M. Pharmacological studies of the large-scale purified genistein from Huaijiao (Sophoara japonica\u2013Leguminosae) on anti-osteoporosis. Phytomedicine. 2006;13:718\u2013723. doi: 10.1016/j.phymed.2005.09.005.", "ArticleIdList": ["10.1016/j.phymed.2005.09.005", "17085294"]}, {"Citation": "Yoon H.J., Seo C.R., Kim M., Kim Y.J., Song N.J., Jang W.S., Kim B.J., Lee J., Hong J.W., Nho C.W., et al. Dichloromethane extracts of Sophora japonica L. stimulate osteoblast differentiation in mesenchymal stem cells. Nutr. Res. 2013;33:1053\u20131062. doi: 10.1016/j.nutres.2013.08.004.", "ArticleIdList": ["10.1016/j.nutres.2013.08.004", "24267045"]}, {"Citation": "Chiou W.F., Lee C.H., Liao J.F., Chen C.C. 8-Prenylkaempferol accelerates osteoblast maturation through bone morphogenetic protein-2/p38 pathway to activate RUNX2 transcription. Life Sci. 2011;88:335\u2013342. doi: 10.1016/j.lfs.2010.12.009.", "ArticleIdList": ["10.1016/j.lfs.2010.12.009", "21163272"]}, {"Citation": "Abdallah H.M., Al-Abd A.M., Asaad G.F., Abdel-Naim A.B., El-halawany A.M. Isolation of antiosteoporotic compounds from seeds of Sophora japonica. PLoS ONE. 2014;9:e98559. doi: 10.1371/journal.pone.0098559.", "ArticleIdList": ["10.1371/journal.pone.0098559", "PMC4043785", "24892557"]}, {"Citation": "Kim J.Y., Kim J.Y., Kim J.J., Oh J., Kim Y.C., Lee M.S. (2S)-2\u2032-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. Biol. Pharm. Bull. 2014;37:255\u2013261. doi: 10.1248/bpb.b13-00695.", "ArticleIdList": ["10.1248/bpb.b13-00695", "24492722"]}, {"Citation": "Yin J., Han N., Xu X., Liu Z., Zhang B., Kadota S. Inhibitory activity of the ethyl acetate fraction from Viscum coloratum on bone resoprtion. Planta Med. 2008;74:120\u2013125. doi: 10.1055/s-2008-1034283.", "ArticleIdList": ["10.1055/s-2008-1034283", "18247260"]}, {"Citation": "Han N., Huang T., Wang Y.C., Yin Y., Kadota S. Flavanone glycosides from Viscum coloratum and their inhibitory effects on osteoclast formation. Chem. Biodiv. 2011;8:1682\u20131688. doi: 10.1002/cbdv.201000289.", "ArticleIdList": ["10.1002/cbdv.201000289", "21922656"]}, {"Citation": "Yin J., Tezuka Y., Kouda K., Tran Q.L., Miyahara T., Chen Y., Kadota S. Antiosteoporotic activity of the water extract of Dioscorea spongiosa. Biol. Pharm. Bull. 2004;27:583\u2013586. doi: 10.1248/bpb.27.583.", "ArticleIdList": ["10.1248/bpb.27.583", "15056872"]}, {"Citation": "Peng K.Y., Horng L.Y., Sung H.C., Huang H.C., Wu R.T. Antiosteoporotic activity of Dioscorea alata L. cv. Phyto through driving mesenchymal stem cell differentiation for bone formation. Evid. Based Complement. Altern. Med. 2011:712892. doi: 10.1155/2011.712892.", "ArticleIdList": ["10.1155/2011.712892", "PMC3132482", "21760825"]}, {"Citation": "Kim S., Shin M.Y., Son K.H., Sohn H.Y., Lim J.H., Lee J.H., Kwun I.S. Yam (Dioscorea batatas) root and bark extracts stimulate osteoblast mineralization by increasing Ca and P accumulation and alkaline phosphatase activity. Prev. Nutr. Food Sci. 2014;19:194\u2013203. doi: 10.3746/pnf.2014.19.3.194.", "ArticleIdList": ["10.3746/pnf.2014.19.3.194", "PMC4195625", "25320717"]}, {"Citation": "Alcantara E.H., Shin M.Y., Sohn H.Y., Park Y.M., Kim T., J.H. L., Jeong H.J., Kwon S.T., Kwun I.S. Diosgenin stimulates osteogenic activity by increasing bone matrix protein synthesis and bone-specific transcription factor Runx2 in osteoblastic MC3T3-E1 cells. J. Nutr. Biochem. 2011;22:1055\u20131063. doi: 10.1016/j.jnutbio.2010.09.003.", "ArticleIdList": ["10.1016/j.jnutbio.2010.09.003", "21292464"]}, {"Citation": "Yin J., Kouda K., Tezuka Y., LeTran Q., Miyahara T., Chen Y., Kadota S. New diarylheptanoids from the rhizomes of Dioscorea spongiosa and their antiosteoporotic activity. Planta Med. 2004;70:54\u201358.", "ArticleIdList": ["14765294"]}, {"Citation": "Yin J., Han N., Liu Z., Song S., Kadota S. The in vitro antiosteoporotic activity of some glycosides in Dioscorea spongiosa. Biol. Pharm. Bull. 2010;33:316\u2013320. doi: 10.1248/bpb.33.316.", "ArticleIdList": ["10.1248/bpb.33.316", "20118560"]}, {"Citation": "Li X., Yang J., He X., Yang Z., Ding Y., Zhao P., Liu Z., Shao H., Li Z., Zhang Y., et al. Identification of upregulators of BMP-2 expression via high-throughput screening of a synthetic and natural compound library. J. Biomol. Screen. 2009;14:1251\u20131256. doi: 10.1177/1087057109346446.", "ArticleIdList": ["10.1177/1087057109346446", "19773586"]}, {"Citation": "Wu J.H., Li Q., Wu M.Y., Guo D.J., Chen H.L., Chen S.L., Seto S.W., Au A.L.S., Poon C.C.W., Leung G.P.H., et al. Formononetin, an isoflavone, relaxes rat isolated aorta through endothelium-dependent and endothelium-indepenent pathways. J. Nutr. Biochem. 2010;21:613\u2013620. doi: 10.1016/j.jnutbio.2009.03.010.", "ArticleIdList": ["10.1016/j.jnutbio.2009.03.010", "19570671"]}, {"Citation": "Ha H., Lee H.Y., Lee J.H., Jung D., Choi J., Song K.Y., Jung H.J., Choi J.S., Chang S.I., Kim C. Formononetin prevents ovariectomy-induced bone loss in rats. Arch. Pharm. Res. 2010;33:625\u2013632. doi: 10.1007/s12272-010-0418-8.", "ArticleIdList": ["10.1007/s12272-010-0418-8", "20422373"]}, {"Citation": "Gautam A.K., Bhargavan B., Tyagi A.M., Srivastava K., Yadav D.K., Kumar A., Singh A., Mishra J.S., Singh A.B., Sanyal S., et al. Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats. J. Nutr. Biochem. 2011;22:318\u2013327. doi: 10.1016/j.jnutbio.2010.02.010.", "ArticleIdList": ["10.1016/j.jnutbio.2010.02.010", "20579866"]}, {"Citation": "Kaczmarczyk-Sedlak I., Wojnar W., Zych M., Ozimina-Kaminska E., Taranowicz J., Siwek A. Effect of formononetin on mechanical properties and chemical composition of bones in rats with ovariectomy-induced osteoporosis. Evid. Based Complement. Altern. Med. 2013:457052. doi: 10.1155/2013/457052.", "ArticleIdList": ["10.1155/2013/457052", "PMC3666393", "23762138"]}, {"Citation": "Rong H.S., Jan F., Deinzer M.L., Cooman L.D., Keukeleire D.D. Identification of isoflavones in the roots of Pueraria lobata. Planta Med. 1998;64:620\u2013627. doi: 10.1055/s-2006-957534.", "ArticleIdList": ["10.1055/s-2006-957534", "17253303"]}, {"Citation": "Feng S., Hao J., Xu Z., Chen T., Qiu S.X. Polyprenylated isoflavone and isoflavonoids from Ormosia henryi and their cytotoxicity and anti-oxidation activity. Fitoterapia. 2012;83:161\u2013165. doi: 10.1016/j.fitote.2011.10.007.", "ArticleIdList": ["10.1016/j.fitote.2011.10.007", "22037567"]}, {"Citation": "Chen W.H., Wang R., Shi Y.P. Flavonoids in the poisonous plant Oxytropis falcata. J. Nat. Prod. 2010;73:1398\u20131403. doi: 10.1021/np100339u.", "ArticleIdList": ["10.1021/np100339u", "20684529"]}, {"Citation": "Srivastava K., Tyagi A.M., Khan K., Dixit M., Lahiri S., Kumar A., Changkija B., Khan M.P., Nagar G.K., Yadav D.K., et al. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis. Phytomedicine. 2013;20:470\u2013480. doi: 10.1016/j.phymed.2012.12.021.", "ArticleIdList": ["10.1016/j.phymed.2012.12.021", "23395215"]}, {"Citation": "Wang X., Zhao L., Liu X., Qi J. Effects of IBP on calcium absorption and biochemical indicators in glucocorticoid-induced osteoporosis rats. Chin. J. Prev. Med. (Zhongguo Yufang Yixue Zazhi) 2011;12:1004\u20131007."}, {"Citation": "Park E., Jin H.S., Cho D.Y., Kim J., Kim M.C., Choi C.W., Jin Y., Lee J.W., Park J.H., Chung Y.S., et al. The effect of lycii Radicis Cortex extract on bone formation in vitro and in vivo. Molecules. 2014;19:19594\u201319609. doi: 10.3390/molecules191219594.", "ArticleIdList": ["10.3390/molecules191219594", "PMC6271141", "25432011"]}, {"Citation": "Yen P.H., Kiem P.V., Nhiem N.X., Tung N.H., Quang T.H., Minh C.V., Kim J.W., Choi E.M., Kim Y.H. A new monoterpene glycoside from the roots of Paeonia lactiflora increases the differentiation of osteoblastic MC3T3-E1 cells. Arch. Pharm. Res. 2007;30:1179\u20131185. doi: 10.1007/BF02980258.", "ArticleIdList": ["10.1007/BF02980258", "18038896"]}, {"Citation": "Appendino G., Spagliardi P., Carvotto G., Pocock V., Milligan S. Daucane phytoestrogens: A structure-activity study. J. Nat. Prod. 2002;65:1612\u20131615. doi: 10.1021/np0201671.", "ArticleIdList": ["10.1021/np0201671", "12444685"]}, {"Citation": "Ikeda K., arao Y., Otsuka H., Nomoto S., Horiguchi H., Kato S., Kayama F. Terpenoids found in the Umbelliferae family act as agonists/antagonists for ER\u03b1 and ER\u03b2: Differential transcription activity between ferutinine-liganded ER\u03b1 and ER\u03b2. Biochem. Biophys. Res. Commun. 2002;291:354\u2013360. doi: 10.1006/bbrc.2002.6446.", "ArticleIdList": ["10.1006/bbrc.2002.6446", "11846412"]}, {"Citation": "Appendino G., Spagliardi P., Sterner O., Milligan S. Structure-activity relationships of the estrogenic sesquiterpene ester ferutinin. Modification of the terpenoid core. J. Nat. Prod. 2004;67:1557\u20131564. doi: 10.1021/np049796w.", "ArticleIdList": ["10.1021/np049796w", "15387659"]}, {"Citation": "Ferretti M., Bertoni L., Cavani F., Zavatti M., Resca E., Carnevale G., Benelli A., Zanoli P., Palumbo C. Influence of ferutinin on bone metabolism in ovariectomized rats. II: Role in recovering osteoporosis. J. Anat. 2010;217:48\u201356. doi: 10.1111/j.1469-7580.2010.01242.x.", "ArticleIdList": ["10.1111/j.1469-7580.2010.01242.x", "PMC2913011", "20492429"]}, {"Citation": "Palumbo C., Ferretti M., Bertoni L., Cavani F., Resca E., Casolari B., Carnevale G., Zavatti M., Montanari C., Benelli A., et al. Influence of ferutinin on bone metabolism in ovariectomized rats. I: Role in preventing osteoporosis. J. Bone Miner. MeTable. 2009;27:538\u2013545. doi: 10.1007/s00774-009-0070-x.", "ArticleIdList": ["10.1007/s00774-009-0070-x", "19333679"]}, {"Citation": "Cavani F., Ferretti M., Carnevale G., Bertoni L., Zavatti M., Palumbo C. Effects of different doses of ferutinin on bone formation/resorption in ovariectomized rats. J. Bone Miner. Metab. 2012;30:619\u2013629. doi: 10.1007/s00774-012-0366-0.", "ArticleIdList": ["10.1007/s00774-012-0366-0", "22828874"]}, {"Citation": "Ferretti M., Bertoni L., Cavani F., Benincasa M., Sena P., Carnevale G., Zavatti M., Viesti V.D., Zanoli P., Palumbo C. Structural and histomorphometric evaluations of ferutinin effects on the uterus of ovariectomized rats during osteoporosis treatment. Life Sci. 2012;90:161\u2013168. doi: 10.1016/j.lfs.2011.11.001.", "ArticleIdList": ["10.1016/j.lfs.2011.11.001", "22100510"]}, {"Citation": "Ferretti M., Cavani F., Manni P., Carnevale G., Bertoni L., Zavatti M., Palumbo C. Ferutinin dose-dependent effects on uterus and mammary gland in ovariectomized rats. Histol. Histopathol. 2014;29:1027\u20131037.", "ArticleIdList": ["24510547"]}, {"Citation": "Zavatti M., Resca E., Bertoni L., Maraldi t., Guida M., Carnevale G., Ferrari A., DePol A. Ferutinin promotes proliferation and osteoblastic differentiation in human amniotic fluid and dental pulp stem cells. Life Sci. 2013;92:993\u20131003. doi: 10.1016/j.lfs.2013.03.018.", "ArticleIdList": ["10.1016/j.lfs.2013.03.018", "23583571"]}, {"Citation": "Zavatti M., Bertoni L., Maraldi T., Resca E., Beretti F., Guida M., LaSala G.B., DePol A. Critical-size bone defect repair using amniotic fluid stem cell/collagen constructs: Effect of oral ferutinin treatment in rats. Life Sci. 2015;121:174\u2013183. doi: 10.1016/j.lfs.2014.10.020.", "ArticleIdList": ["10.1016/j.lfs.2014.10.020", "25445219"]}, {"Citation": "Park E.J., Pezzuto J.M. The pharmacology of resveratrol in animals and humans. Biochim. Biophys. Acta. 2015;1852:1071\u20131113. doi: 10.1016/j.bbadis.2015.01.014.", "ArticleIdList": ["10.1016/j.bbadis.2015.01.014", "25652123"]}, {"Citation": "Mobasheri A., Shakibaei M. Osteogenic effects of resveratrol in vitro: Potential for the prevention and treatment of osteoporosis. Ann. N. Y. Acad. Sci. 2013;1290:59\u201366. doi: 10.1111/nyas.12145.", "ArticleIdList": ["10.1111/nyas.12145", "23855466"]}, {"Citation": "Tou J.C. Evaluating resveratrol as a therapeutic bone agent: Preclinical evidence from rat models of osteoporosis. Ann. N. Y. Acad. Sci. 2015;1348:75\u201385. doi: 10.1111/nyas.12840.", "ArticleIdList": ["10.1111/nyas.12840", "26200189"]}, {"Citation": "Mizutani K., Ikeda K., Kawai Y., Yamori Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 1998;253:859\u2013863. doi: 10.1006/bbrc.1998.9870.", "ArticleIdList": ["10.1006/bbrc.1998.9870", "9918820"]}, {"Citation": "Dai Z., Li Y., Quarles L.D., Song T., Pan W., Zhou H., Xiao Z. Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine. 2007;14:806\u2013814. doi: 10.1016/j.phymed.2007.04.003.", "ArticleIdList": ["10.1016/j.phymed.2007.04.003", "17689939"]}, {"Citation": "Zhou H., Shang L., Li X., Zhang X., Gao G., Guo C., Chen B., Liu Q., Gong Y., Shao C. Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells. Exp. Cell Res. 2009;315:2953\u20132962. doi: 10.1016/j.yexcr.2009.07.030.", "ArticleIdList": ["10.1016/j.yexcr.2009.07.030", "19665018"]}, {"Citation": "Tseng P.C., Hou S.M., Chen R.J., Peng H.W., Hsieh C.F., Kuo M.L., Yen M.L. Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis. J. Bone Miner. Res. 2011;26:2552\u20132563. doi: 10.1002/jbmr.460.", "ArticleIdList": ["10.1002/jbmr.460", "21713995"]}, {"Citation": "Shakibaei M., Shayan P., Busch F., Aldinger C., Buhrmann C., Lueders C., Mobasheri A. Resveratrol mediated modulation of SIRT-1/RUNX2 promotes osteogenic differentiation of mesenchymal stem cells: Potential role of RUNX2 deacetylation. PLoS ONE. 2012;7:e35712. doi: 10.1371/journal.pone.0035712.", "ArticleIdList": ["10.1371/journal.pone.0035712", "PMC3335081", "22539994"]}, {"Citation": "He X., Andersson G., Lindgren U., Li Y. Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW264.7 cells through inhibition of ROS production. Biochem. Biophys. Res. Commun. 2010;401:356\u2013362. doi: 10.1016/j.bbrc.2010.09.053.", "ArticleIdList": ["10.1016/j.bbrc.2010.09.053", "20851107"]}, {"Citation": "Shakibaei M., Buhrmann C., Mobasheri A. Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-\u03baB ligand (RANKL) activation of NF-\u03baB signaling and inhibit osteoclastogenesis in bone-derived cells. J. Biol. Chem. 2011;286:11492\u201311505. doi: 10.1074/jbc.M110.198713.", "ArticleIdList": ["10.1074/jbc.M110.198713", "PMC3064204", "21239502"]}, {"Citation": "Tou J.C. Resveratrol supplementation affects bone acquisition and osteoporosis: Pre-clinical evidence toward translational diet therapy. Biochim. Biophys. Acta. 2015;1852:1186\u20131194. doi: 10.1016/j.bbadis.2014.10.003.", "ArticleIdList": ["10.1016/j.bbadis.2014.10.003", "25315301"]}, {"Citation": "Liu Z.P., Li W.X., Yu B., Huang J., Sun J., Huo J.S., Liu C.X. Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model. J. Med. Food. 2005;8:14\u201319. doi: 10.1089/jmf.2005.8.14.", "ArticleIdList": ["10.1089/jmf.2005.8.14", "15857203"]}, {"Citation": "Zhao H., Li X., Li N., Liu T., Liu J., Li Z., Xiao H., Li J. Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus. Br. J. Nutr. 2014;111:836\u2013846. doi: 10.1017/S0007114513003115.", "ArticleIdList": ["10.1017/S0007114513003115", "24073920"]}, {"Citation": "Habold C., Momken I., Ouadi A., Bekaert V., Brasse D. Effect of prior treatment with resveratrol on density and structure of rat long bones under tail-suspension. J. Bone Miner. Metab. 2011;29:15\u201322. doi: 10.1007/s00774-010-0187-y.", "ArticleIdList": ["10.1007/s00774-010-0187-y", "20458604"]}, {"Citation": "Durbin S.M., Jackson J.R., Tyan M.J., Gigliotti J.C., Alway S.E., Tou J.C. Resveratrol supplementation influences bone properties in the tibia of hindlimb-suspended mature Fisher 344 x Brown Norway male rats. Appl. Physiol. Nutr. MeTable. 2012;37:1179\u20131188. doi: 10.1139/h2012-099.", "ArticleIdList": ["10.1139/h2012-099", "23050779"]}, {"Citation": "Wang H.D., Shi Y.M., Li L., Guo J.D., Zhang Y.P., Hou S.X. Treatment with resveratrol attenuates sublesional bone loss in spinal cord-injured rats. Br. J. Pharmacol. 2013;170:796\u2013806. doi: 10.1111/bph.12301.", "ArticleIdList": ["10.1111/bph.12301", "PMC3799594", "23848300"]}, {"Citation": "Casarin R.C., Casati M.Z., Pimentel S.P., Cirano F.R., Algayer M., Pires P.R., Ghiraldini B., Duarte P.M., Ribeiro F.V. Resveratrol improves bone repair by moduation of bone morphogenetic proteins and osteopontin gene expression in rats. Int. J. Oral Maxillofac. Surg. 2014;43:900\u2013906. doi: 10.1016/j.ijom.2014.01.009.", "ArticleIdList": ["10.1016/j.ijom.2014.01.009", "24530035"]}, {"Citation": "Tresguerres I.F., Tamimi F., Eimar H., Barralet J., Torres J., Blanco L., Tresguerres J.A.F. Resveratrol as anti-aging therapy for age-related bone loss. Rejuvenation Res. 2014;17:439\u2013445. doi: 10.1089/rej.2014.1551.", "ArticleIdList": ["10.1089/rej.2014.1551", "24956408"]}, {"Citation": "Durbin S.M., Jackson J.R., Ryan M.J., Gigliotti J.C., Alway S.E., Tou J.C. Resveratrol supplementation preserves long bone mass, microstructure, and strength in hindlimb-suspended old male rats. J. Bone Miner. Metab. 2014;32:38\u201347. doi: 10.1007/s00774-013-0469-2.", "ArticleIdList": ["10.1007/s00774-013-0469-2", "23686002"]}, {"Citation": "Li Y., Danmark S., Edlund U., Finne-Wistrand A., He X., Norgard M., Blomen E., Hutenby K., Andersson G., Lindgren U. Resveratrol-conjugated poly-\u03b5-caprolactone facilitates in vitro mineralization and in vivo bone regeneration. Acta Biomater. 2011;7:751\u2013758. doi: 10.1016/j.actbio.2010.09.008.", "ArticleIdList": ["10.1016/j.actbio.2010.09.008", "20849988"]}, {"Citation": "Cui L., Wu T., Li Q.N., Lin L.S., Liang N.C. Preventive effects of ginsenosides on osteopenia of rats induced by ovariectomy. Acta Pharmacol. Sin. 2001;22:428\u2013434.", "ArticleIdList": ["11743891"]}, {"Citation": "Gong Y.S., Chen J., Zhang Q.Z., Zhang J.T. Effects of 17-\u03b2-oestradiol and ginsenoside on osteoporosis in ovariectomized rats. J. Asian Nat. Prod. Res. 2006;8:649\u2013656. doi: 10.1080/10286020500246063.", "ArticleIdList": ["10.1080/10286020500246063", "17135052"]}, {"Citation": "Cheng B., Li J., Du J., Lv X., Weng L., Ling C. Ginsenoside Rb1 inhibits osteoclastogenesis by modulating NF-\u03baB and MAPKS pathways. Food Chem. Toxicol. 2012;50:1610\u20131615. doi: 10.1016/j.fct.2012.02.019.", "ArticleIdList": ["10.1016/j.fct.2012.02.019", "22386813"]}, {"Citation": "Huang Q., Gao B., Jie Q., Wei B.Y., Fan J., Zhang H.Y., Zhang J.K., Li X.J., Shi J., Luo Z.J., et al. Ginsenoside-Rb2 displays anti-osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis. Bone. 2014;66:306\u2013314. doi: 10.1016/j.bone.2014.06.010.", "ArticleIdList": ["10.1016/j.bone.2014.06.010", "24933344"]}, {"Citation": "Gao B., Huang Q., Jie Q., Zhang H.Y., Wang L., Guo Y.S., Sun Z., Wei B.Y., Han Y.H., Liu J., et al. Ginsenoside-Rb2 inhibits dexamethasone-induced apoptosis through promotion of GPR120 induction in bone marrow-derived mesenchymal stem cells. Stem Cells Dev. 2015;24:781\u2013790. doi: 10.1089/scd.2014.0367.", "ArticleIdList": ["10.1089/scd.2014.0367", "25314926"]}, {"Citation": "Kim D.Y., Park Y.G., Quan H.Y., Kim S.J., Jung M.S., Chung S.H. Ginsenoside Rd stimulates the differentiation and mineralization of osteoblastic MC3T3-E1 cells by activating AMP-activated protein kinase via the BMP-2 signaling pathway. Fitoterapia. 2012;83:215\u2013222. doi: 10.1016/j.fitote.2011.10.017.", "ArticleIdList": ["10.1016/j.fitote.2011.10.017", "22061660"]}, {"Citation": "Yin L.H., Cheng W.X., Qin Z.S., Sun K.M., Zhong M., Wang J.K., Gao W.Y., Yu Z.H. Effects of ginsenoside Rg1 on the proliferation and osteogenic differentiation of human periodontal ligament stem cells. Chin. J. Integr. Med. 2015;21:676\u2013681. doi: 10.1007/s11655-014-1856-9.", "ArticleIdList": ["10.1007/s11655-014-1856-9", "25491536"]}, {"Citation": "Wang P., Wei X., Zhang F., Yang K., Qu C., Luo H., He L. Ginsenoside Rg1 of Panax ginseng stimulates the proliferation, odontogenic/osteogenic differentiation and gene expression profiles of human dental pulp stem cells. Phytomedicine. 2014;21:177\u2013183. doi: 10.1016/j.phymed.2013.08.021.", "ArticleIdList": ["10.1016/j.phymed.2013.08.021", "24075212"]}, {"Citation": "Chen W.F., Gao Q.G., Dai Z.J., Kung A.W., Guo D.A., Wong M.S. Estrogenic effects of ginsenoside Rg1 in endometrial cells in vitro were not observed in immature CD-1 mice or ovariectomized mice model. Menopause. 2012;19:1052\u20131061. doi: 10.1097/gme.0b013e318250361c.", "ArticleIdList": ["10.1097/gme.0b013e318250361c", "22549169"]}, {"Citation": "Siddiqi M.H., Siddiqi M.Z., Kang S., Noh H.Y., Ahn S., Simu S.Y., Aziz M.A., Sathishkumar N., Perez Z.E.J., Yang D.C. Inhibition of osteoclast differentiation by ginsenoside Rg3 in RAW264.7 cells via RANKL, JNK and p38 MAPK pathways through a modulation of cathepsin K: An in silico and in vitro study. Phytother. Res. 2015;29:1286\u20131296. doi: 10.1002/ptr.5374.", "ArticleIdList": ["10.1002/ptr.5374", "26059856"]}, {"Citation": "Siddiqi M.Z., Siddiqi M.H., Kim Y.J., Jin Y., Huq M.A., Yang D.C. Effect of fermented red ginseng extract enriched in ginsenoside Rg3 on the differentiation and mineralization of preosteoblastic MC3T3-E1 cells. J. Med. Food. 2015;18:542\u2013548. doi: 10.1089/jmf.2014.3251.", "ArticleIdList": ["10.1089/jmf.2014.3251", "PMC4410546", "25764149"]}, {"Citation": "Siddiqi M.H., Siddiqi M.Z., Ahn S., Kang S., Kim Y.J., Veerappan K., Yang D.U., Yang D.C. Stimulative effect of ginsenosides Rg5:Rk1 on murine osteoblastic MC3T3-E1 cells. Phytother. Res. 2014;28:1447\u20131455. doi: 10.1002/ptr.5146.", "ArticleIdList": ["10.1002/ptr.5146", "24643957"]}, {"Citation": "Siddiqi M.H., Siddiqi M.Z., Ahn S., Kim Y.J., Yang D.C. Ginsenoside Rh1 induces mouse osteoblast growth and differentiation through the bone morphogenetic protein 2/RUNT-related gene 2 signalling pathway. J. Pharm. Pharmacol. 2014;66:1763\u20131773. doi: 10.1111/jphp.12306.", "ArticleIdList": ["10.1111/jphp.12306", "25154440"]}, {"Citation": "He L., Lee J., Jang J.H., Lee S.H., Nan M.H., Oh B.C., Lee S.G., Kim H.H., Soung N.K., Ahn J.S., et al. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-\u03baB, NFATc1 and c-Fos. Bone. 2012;50:1207\u20131213. doi: 10.1016/j.bone.2012.03.022.", "ArticleIdList": ["10.1016/j.bone.2012.03.022", "22484180"]}, {"Citation": "Liu J., Shiono J., Shimizu K., Yu H., Zhang C., Jin F., Kondo R. 20(R)-Ginsenoside Rh2, not 20(S), is a selective osteoclastogenesis inhibitor without any cytotoxicity. Bioorg. Med. Chem. Lett. 2009;19:3320\u20133323. doi: 10.1016/j.bmcl.2009.04.054.", "ArticleIdList": ["10.1016/j.bmcl.2009.04.054", "19428246"]}, {"Citation": "Kim D.Y., Jung M.S., Park Y.G., Yuan H.D., Quan H.Y., Chung S.H. Ginsenosdie Rh2(S) induces the differentiation and mineralization of osteoblastic MC3T3-E1 cells through activation of PKD and p38 MAPK pathways. BMB Rep. 2011;44:659\u2013664.", "ArticleIdList": ["22026999"]}, {"Citation": "Kim D.Y., Park K.H., Jung M.S., Huang B., Yuan H.D., Quan H.Y., Chung S.H. Gensenoside Rh2(S) induces differentiation and mineralization of MC3T3-E1 cells through activation of the PKD/AMPK signaling pathways. Int. J. Mol. Med. 2011;28:753\u2013759.", "ArticleIdList": ["21769419"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "12", "Day": "9"}, {"Year": "2016", "Month": "2", "Day": "3"}, {"Year": "2016", "Month": "2", "Day": "12"}, {"Year": "2016", "Month": "3", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "3", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "11", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "2", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["26927052", "PMC6274145", "10.3390/molecules21030239", "molecules21030239"]}}], "PubmedBookArticle": []}